[Federal Register Volume 67, Number 78 (Tuesday, April 23, 2002)]
[Notices]
[Pages 19932-19950]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-9724]



[[Page 19931]]

-----------------------------------------------------------------------

Part VII





Department of Health and Human Services





-----------------------------------------------------------------------



Centers for Disease Control and Prevention



-----------------------------------------------------------------------



National Cancer Prevention and Control Program; Notice of Availability 
of Funds; Notice

  Federal Register / Vol. 67, No. 78 / Tuesday, April 23, 2002 / 
Notices  

[[Page 19932]]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[Program Announcement 02060]


National Cancer Prevention and Control Program; Notice of 
Availability of Funds

A. Purpose

    The Centers for Disease Control and Prevention (CDC) announces the 
availability of fiscal year (FY) 2002 funds for a cooperative agreement 
program for the National Cancer Prevention and Control Program (NCPCP). 
This program addresses the ``Healthy People 2010'' focus area(s) 
related to cancer.
    This Program Announcement is issued in an effort to simplify and 
streamline the grant pre-award and post-award administrative process, 
measure performance related to each grantee's stated objectives and 
identify and establish the long-term goals of a NCPCP program through 
stated performance measures. Examples of the benefits of the 
streamlined process are: consistency in reporting expectations; and the 
ability for grantees to advance to the Implementation level for the 
National Comprehensive Cancer Control Program (NCCCP) or Enhancement 
level for the National Program of Cancer Registries (NPCR) based on 
performance when funds are available.
    This Announcement incorporates funding guidance for the following 
three components: the National Comprehensive Cancer Control Program 
(NCCCP) (previously awarded under Program Announcements #99046, and 
#01115); the National Breast and Cervical Cancer Early Detection 
Program (NBCCEDP), (previously awarded under Program Announcements 
#97018, #96023, #99052, and #01038); and the National Program of Cancer 
Registries (NPCR) (previously awarded under Program Announcement 
#00027).
    The NCPCP will assist States/District of Columbia/Tribes/
Territories in developing, implementing, maintaining, enhancing, 
integrating, and evaluating a cancer program inclusive of cancer 
surveillance, prevention and early detection programs, and which 
focuses on eliminating health disparities. The purpose of each of the 
three programmatic components within the NCPCP follows.

A.1. NCCCP

    The NCCCP component supports the planning and implementation of 
comprehensive cancer control activities. CDC defines comprehensive 
cancer control as an integrated and coordinated approach to reduce the 
incidence, morbidity and mortality of cancer through prevention, early 
detection, treatment, rehabilitation, and palliation.

A.2. NBCCEDP

    The NBCCEDP component supports the development of systems to assure 
breast and cervical cancer screening for low income, underserved, 
uninsured women with special emphasis on reaching those who are 
geographically or culturally isolated, older, or members of racial/
ethnic minorities. Components of the NBCCEDP include surveillance, 
partnership development, screening, referral and follow-up, quality 
assurance, public and provider education, and evaluation. These 
components are carried out at the local, State and national levels 
through collaborative partnerships with State health agencies, 
community-based organizations, tribal governments, universities, a 
variety of medical care providers and related agencies and 
institutions, and the business and voluntary sectors. These partners 
work together to develop, implement and evaluate strategies to promote 
breast and cervical cancer prevention and early detection, to increase 
access to related services and to improve the quality and timeliness of 
the services.

A.3. NPCR

    The NPCR component supports efforts to establish population-based 
cancer registries where they do not exist and to improve existing 
cancer registries.
    Throughout this program announcement, to the extent possible, 
information that is specific to the three individual components has 
been grouped into a section that addresses that component only. Section 
G ``Specific Guidance for NCCCP'' addresses the National Comprehensive 
Cancer Control Program; Section H ``Specific Guidance for NCCEDP'' 
addresses the National Breast and Cervical Cancer Early Detection 
Program; and Section I ``Specific Guidance for NPCR'' addresses the 
National Program of Cancer Registries. These component sections include 
specific guidance regarding:
     Eligibility
     Availability of Funds
     Program Requirements
     Content
     Other Requirements
     Evaluation Criteria
    Please refer to these specific component sections for information.

Special Guidelines for Technical Assistance

    Conference Call: Technical assistance will be available for 
potential applicants on three conference calls.
    The first call will be for States/Tribes/Territories that are in 
atlantic, eastern, or central time zones, and will be held on April 29, 
2002 from 9:00 a.m. to 11:00 a.m. (eastern time).
    The second call will be for States/Tribes/Territories that are in 
mountain or pacific time zones, and will be held on April 29, 2002 from 
3:30 p.m. to 5:30 p.m. (eastern time).
    While all information disseminated will be consistent throughout 
the calls, a third call will be held particularly for tribal and 
territorial organizations on April 30, 2002 from 4:00 p.m. to 6:00 p.m. 
(eastern time).
    Potential applicants are requested to call in using only one 
telephone line. The conference can be accessed by calling 1-800-713-
1971 or 404-639-4100, and entering access code 285614. The purpose of 
the conference call is to help potential applicants to:
    1. Understand the scope and intent of the Program Announcement for 
the National Cancer Prevention and Control Program;
    2. Be familiar with the Public Health Services funding policies and 
application and review procedures.
    Participation in this conference call is not mandatory. At the time 
of the call, if you have problems accessing the conference call, please 
call 404-639-7550.

B. Eligible Applicants

    Applicants may apply for any or all of the components within this 
program announcement for which they are eligible.

B.1.  Eligible for All Components

    Potential applicants that are eligible for all components are the 
health departments of States or their bona fide agents, the District of 
Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the 
Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the 
Federated States of Micronesia, the Republic of the Marshall Islands, 
and the Republic of Palau. (See also Attachment A--Eligibility Table in 
the appendices.)

B.2.  Eligible for Specific Components/Guidance

    In addition to the eligible applicants listed above, potential 
applicants that are eligible for specific components are:

[[Page 19933]]

B.2.a.  NCCCP
    Federally recognized Indian tribal governments and tribal 
organizations.
B.2.b.  NBCCEDP
    Federally recognized Indian Tribal governments and Tribal 
organizations, urban Indian organizations and inter-tribal consortia 
(hereafter referred to as Tribes) whose primary purpose is to improve 
American Indian/Alaska Native health and which represent the Native 
population in their catchment area.
B.2.c.  NPCR
    Academic or nonprofit organizations designated by the State to 
operate the State's cancer registry.
    State health departments are uniquely qualified to define the 
cancer problem throughout the State, to plan and develop statewide 
strategies to reduce the burden of cancer, to provide overall State 
coordination of cancer prevention and control activities among 
partners, to lead and direct communities, to direct and oversee 
interventions within overarching State policies, and to monitor 
critical aspects of cancer.

    Note: Title 2 of the United States Code section 1611 states that 
an organization described in section 501(c)(4) of the Internal 
Revenue Code that engages in lobbying activities is not eligible to 
receive Federal funds constituting an award, grant or loan.

C. Availability of Funds

    Approximately $178,000,000 is available in FY 2002 to fund 
approximately 75 awards.
    It is expected that awards under this program announcement will 
begin on or about September 30, 2002, and will be made for a 9 month 
budget period for the first year which will end on June 29, 2003. 
Future budget periods will be 12 month periods, and will begin on June 
30 of every year and run through June 29 of each following year. These 
budget periods will occur within a project period of up to five years. 
Funding estimates may change.
    The level of competitiveness varies within this program 
announcement for each component based on whether a program is currently 
funded, and if funded, based on the current project period. All non-
competitive applications will be reviewed by a Technical Acceptability 
Review process. All competitive applications for the NCCCP component 
will be reviewed by an Independent Objective Review Panel. Competitive 
applications submitted for NBCCEDP and NPCR components will undergo a 
Technical Acceptability Review process for applications received from 
States and an Independent Objective Review for applications received 
from Tribes and Territories.
    Existing grantees, under Program Announcement Numbers 01115 (for 
NCCCP--Planning and Implementation Recipients), 99052, and 01038 (for 
NBCCEDP), or 00027 (for NPCR), will have their existing project periods 
extended to FY 2007 upon receipt of a technically acceptable 
application. Applications for these funds will be reviewed as non-
competitive.
    All currently funded programs whose project periods end this 
calendar year, as well as any new applicants, will submit competitive 
applications.
    Continuation awards within an approved project period will be made 
on the basis of satisfactory progress as evidenced by required progress 
reports and the availability of funds.

C.1. Component Funding

    For specific ``Component Funding'' information, please see Sections 
G, H, and I.

C.2. Requested Budget Information

    Applicants should submit separate budgets for each component (as 
well as separate budgets if applying for the Optional Funding under 
NCCCP) in response to this program announcement. Each detailed budget 
and narrative justification should support the activities for year one 
funding in response to this Program Announcement for FY 2002 support.
    Current recipients' unobligated funds from the immediately prior 
budget period may be rolled into successful recipients' new awards 
unless they are currently in the last year of an existing project 
period.
    Applications should follow the guidance below with respect to the 
development and submission of an itemized budget and justification for 
each component.

C.3. Use of Funds

    For specific ``Use of Funds'' information, please see Sections G, 
H, and I.
    Cooperative agreement funds may be used to support personnel and to 
purchase equipment, supplies, and services directly related to project 
activities and consistent with the scope of the cooperative agreement.
    Funds provided under this program announcement may not be used to:
     Conduct research projects. Guidance regarding CDC's 
definition of ``research'' should be reviewed at http://www.cdc.gov/od/ads/opspoll1.htm.
     Supplant State or local funds, to provide inpatient care 
or treatment, or to support the construction or renovation of 
facilities.
    Applicants are encouraged to identify and leverage mutually 
beneficial opportunities to interact and integrate with other State 
health department programs that address related chronic diseases or 
risk factors. This may include cost sharing to support a shared 
position such as a Chronic Disease Epidemiologist, Health Communication 
Specialist, Program Evaluator, or Policy Analyst to work on relevant 
activities across units/departments within the State health department. 
Such activities may include, but are not limited to, joint planning, 
joint funding of complementary activities, public health education, 
collaborative development and implementation of environmental, policy, 
systems, or community interventions and other cost sharing activities.

C.4. Recipient Financial Participation

    For specific ``Recipient Financial Participation'' information, 
please see Sections G, H, and I.

C.5. Direct Assistance

    For specific ``Direct Assistance'' information, please see Sections 
G, H, and I.

C.6. Funding Preferences

    For specific ``Funding Preference'' information, please see 
Sections G, H, and I.

C.7. Funding Consideration

    For specific ``Funding Consideration'' information, please see 
Sections G, H, and I.

D. Content

D.1. Letter of Intent

    One Letter of Intent (LOI) is requested from each applicant 
applying for any component(s) of this program. The narrative should be 
no more than one single-spaced page, printed on one side, with one inch 
margins, and unreduced font. Your LOI will not be evaluated, but will 
be used to assist CDC in planning for the objective review for this 
program and should include the announcement number, the specific 
component(s) and parts of the component, if applicable, for which funds 
are being applied, and the name of the principal investigator.

D.2. Application Development

    Use the information in the Program Requirements, Other 
Requirements, and Evaluation Criteria sections to develop the 
application content. Your application will be evaluated using the 
criteria listed, so it is important to follow them in laying out your 
program plan.

[[Page 19934]]

    Applications should follow the guidance below with respect to page 
limitations for each component. All applications should be printed on 
one side, with one inch margins, using unreduced font. All materials 
must be provided in an unbound, one-sided, 8\1/2\  x  11" print format, 
suitable for photocopying (i.e., no audiovisual materials, posters, 
tapes, etc.).

D.3. Page Limitations

    For specific ``Page Limitations'' information, please see Sections 
G, H, and I.

D.4 Application Outline

    Applicants may apply for any or all of the components within this 
program announcement for which they are eligible. Please provide 
specific ``Application Outline'' information for each component as 
outlined in specific Sections G, H, and I.

E. Submission and Deadline

E.1. Letter of Intent

    On or before May 15, 2002, submit the LOI to the Grants Management 
Specialist identified in the ``Where to Obtain Additional Information'' 
section of this announcement.

E.2. Application

    Submit the original and two copies of CDC Form 0.1246. Forms are 
available in the application kit and at the following Internet address: 
www.cdc.gov/od/pgo/forminfo.htm
    On or before June 20, 2002, submit the original and two copies of 
the application to:
    Technical Information Management (TIM), Procurement and Grants 
Office, Centers for Disease Control and Prevention, 2920 Brandywine 
Road, Room 3000, Atlanta, GA 30341-4146.
    Please reference Program Announcement Number 02060 National Cancer 
Prevention and Control Program on the mailing envelope and on the 
application Standard Form 424, block 11. Please also make sure that 
block 16 on Standard Form 424, regarding Executive Order 12372 has been 
completed correctly.

E.3. Deadline

    Applications shall be considered as meeting the deadline if they 
are received on or before the deadline date.

F. Evaluation Criteria

    Each application will be evaluated individually against the 
following criteria by either a Technical Acceptability Review Panel or 
an Independent Review Group appointed by CDC.
    For specific ``Evaluation Criteria'' information, please see 
Sections G, H, and I.

G. Specific Guidance for the National Comprehensive Cancer Control 
Program (NCCCP)

G.1. Eligible Applicants

    The NCCCP component of this Program Announcement incorporates two 
types of eligibility. The first type is a Planning Program. Applicants 
who are in the planning phase of establishing a State/Tribe/Territory 
wide comprehensive cancer control plan should apply as a Planning 
Program.
    The second type of NCCCP eligibility is an Implementation Program. 
Applicants who have already established a comprehensive cancer control 
plan and need to begin implementing established priorities should apply 
as an Implementation Program.
    Applicants are eligible for Planning or Implementation Program 
funding, but not both.

G.2. Availability of Funds

    Approximately $2,800,000 is available to fund 14 existing NCCCP 
grantees under Program Announcement Number 01115. It is expected that 
the average amount for NCCCP Planning Program recipients will be 
$125,000, ranging from $100,000 to $150,000 for a project period of up 
to five years. The average amount for NCCCP Implementation Program 
recipients will be $250,000, ranging from $200,000 to $300,000 for a 
project period of up to five years.
    In addition, approximately $1,280,000 is available in FY 2002 to 
fund five to eight new NCCCP recipients. The average award, range of 
awards, and project period for these awards are the same as above.
    Existing grantees awarded under NCCCP Program Announcement Number 
99046 should apply for this component competitively. If the applicant 
competes successfully, a new award number under this program 
announcement will be issued for a new five year project period. If the 
applicant is unsuccessful, the project period previously awarded under 
Program Announcement Number 99046 will remain and expire at its 
originally anticipated date of November 30, 2002.
    Pending availability of funds, each year of the project period for 
this overall program announcement (9/30/02-6/29/07) will incorporate an 
open season for competitive applications for the NCCCP component with 
applications due on or about February 28. (Specific guidance with exact 
dates to be provided in future years.) At that time, eligible 
applicants may apply for Planning funds or Implementation funds but not 
both.
    In future budget years, Planning Program recipients demonstrating 
success in meeting Planning Program Performance Measures and fulfilling 
the requirements to advance to the Implementation Program may request 
Implementation Program funding before the end of the full five year 
project period. Applicants who do not submit technically acceptable 
applications for Implementation funding under this scenario would 
continue receiving Planning funding support.

Optional Additional NCCCP Funds

    Additional optional funding for NCCCP (Implementation recipients 
only) is available for the implementation of Cancer Plan priorities 
related to colorectal, ovarian, prostate, and skin cancers. 
Approximately $3.9 million will be distributed to support activities as 
follows:
     Colorectal cancer activities--$1,000,000
     Ovarian cancer activities--$1,000,000
     Prostate cancer activities--$1,500,000
     Skin cancer activities--$475,000
    Approximately 15 awards to successful Implementation Program 
recipients are anticipated with these additional funds. It is expected 
that the average amount for this optional component will be $300,000, 
and will range from $100,000 to $700,000. These awards will be for a 
project period of up to five years with the exception of activities 
related to skin cancer. Skin cancer activities will be funded for a one 
year period only. These applications will be reviewed by an Independent 
Objective Review Panel.
G.2.a. Direct Assistance
    Applicants may request Federal personnel, as direct assistance, in 
lieu of a portion of financial assistance.
    Requests for new direct-assistance should include:
G.2.a.(1) Number of assignees requested;
G.2.a.(2) Description of the position and proposed duties;
G.2.a.(3) Ability or inability to hire locally with financial 
assistance;
G.2.a.(4) Justification for request;
G.2.a.(5) Organizational chart and name of intended supervisor;
G.2.a.(6) Opportunities for training, education, and work experiences 
for assignees; and
G.2.a.(7) Description of assignee's access to computer equipment for 
communication with CDC (e.g.,

[[Page 19935]]

personal computer at home, personal computer at workstation, shared 
computer at workstation on site, shared computer at a central office).
G.2.b. Use of Funds
    These funds should not be used to support other existing 
categorical programs such as breast and cervical cancer screening, 
cancer registry, laboratory or clinical services, or tobacco control 
programs. Funds awarded under this program announcement may not be used 
to supplant existing program efforts. Funds may not be used to provide 
direct medical care.
G.2.c. Recipient Financial Participation
    Recipient financial participation is not required for this program 
in years 1-2 of funding. Recipient financial participation may be 
required in years 3-5 in an amount not less than one dollar for each 
three dollars of Federal funds awarded under this program.
G.2.d. Funding Preference
    There are no funding preferences applicable to this component.
G.2.e. Funding Consideration
    Funding consideration for the NCCCP component may be based on:
    G.2.e.(1) Total amount of funding available to support the NCCCP. 
See G.2. ``Availability of Funds'' for this information.
    G.2.e.(2) The proportion of funds awarded for NCCCP activities that 
were spent during the budget period, if such funds were received in the 
past.
    G.2.e.(3) The appropriate and timely use of unobligated funds from 
previous years, if such funds were received in the past.

G.3. Program Requirements for NCCCP

    In conducting activities to achieve the purpose of this program, 
the recipient will be responsible for conducting the activities under 
G.3.a. (Recipient Activities) and CDC will be responsible for the 
activities listed under G.3.b. (CDC Activities). All NCCCP recipient 
activity efforts to address tobacco use, poor oral health, poor 
nutrition, physical inactivity, and school health should be coordinated 
with State Programs focused on tobacco, oral health, nutrition, 
physical activity, and coordinated school health programs. Activities 
of these programs should not be duplicated.

G.3.a. Recipient Activities

    CDC has developed performance measures to evaluate recipients' 
progress in meeting NCCCP requirements. These performance measures are 
listed following each associated recipient activity.
    G.3.a.(1) Planning Activities:
    G.3.a.(1)(a) Enhance comprehensive cancer control infrastructure by 
acquiring key staff and associated resources to produce a State/Tribe/
Territory-wide comprehensive cancer control plan. Performance will be 
measured by the extent to which the program has (a) put in place the 
infrastructure for NCCCP including staff and other resources and (b) 
generated support, resources or secured funding to support NCCCP 
activities.
    G.3.a.(1)(b) Mobilize support for comprehensive cancer control 
planning activities by assessing and building support among the public 
and private sectors. Build partnerships by identifying, contacting and 
inviting potential key private, professional, voluntary, and nonprofit 
cancer control organizations, policymakers, consumers, payers, media, 
State and Federal agencies, surveillance and data agencies, research 
and academic institutions, and others to become members of a new or 
existing State/Tribe/Territory-wide comprehensive cancer control 
coalition/partnership. Performance will be measured by the extent to 
which the program has developed or used coalitions and partners, both 
within (such as Breast and Cervical Cancer Early Detection Programs and 
the State or Territorial Central Cancer Registry) and outside of the 
organization and sustained these partnerships as ongoing entities by 
such activities as:

G.3.a.(1)(b)[1] Establishing written responsibilities (e.g., in a 
mission statement or scope of work);
G.3.a.(1)(b)[2] Establishing written inter-organizational linkages 
(e.g., a Memorandum of Understanding);
G.3.a.(1)(b)[3] Conducting formal assessment of members' skills and 
needs for education or training; or
G.3.a.(1)(b)[4] Conducting assessments of partnership member 
satisfaction.

    G.3.a.(1)(c) Assess and address the State/Tribe/Territory cancer 
burden to determine the critical target areas for cancer prevention and 
control activities; assess gaps in strategies to address the cancer 
burden; develop a comprehensive cancer control plan that includes 
prioritized measurable goals and objectives; and identify implementing 
organizations for priority plan strategies. Performance will be 
measured by the extent to which the program has developed and used data 
(such as that which is available from the State or territorial central 
cancer registry) to define the cancer burden, set priorities and choose 
appropriate intervention strategies.
    G.3.a.(1)(d) Conduct systematic evaluation of the comprehensive 
cancer control planning process and the program through identifying 
resources and staff for evaluation, defining planning evaluation 
questions, assessing the planning process, and identifying emerging 
challenges, solutions and outcomes of the planning process. The 
applicant should develop objective/quantitative measures of 
effectiveness that will demonstrate accomplishment of program goals and 
objectives and measure intended outcomes. These measures of 
effectiveness, through which the program will assess its own 
activities, should be specific to proposed activities in the work plan 
and should be submitted as part of this application. Performance will 
be measured by the extent to which the program has:
    G.3.a.(1)(d)[1] Continuously evaluated and monitored its own 
process, objectives and activities.
    G.3.a.(1)(d)[2] Developed and monitored measures of effectiveness 
for its proposed activities.
    G.3.a.(2) Implementation Activities:
    G.3.a.(2)(a) Implement priorities as established by the State/
Tribe/Territory's comprehensive cancer control plan, which provides a 
framework for action to reduce the burden of cancer in the State/Tribe/
Territory. Update and modify plan priorities and strategies to enable 
continual identification of critical target areas for cancer prevention 
and control activities; assess gaps in existing strategies to address 
the cancer burden; and prioritize and identify implementing 
organizations for emerging priority plan strategies.
    Performance will be measured by the extent to which the program 
has:
    G.3.a.(2)(a)[1] Identified partners who are implementing cancer 
control plan activities/strategies.
    G.3.a.(2)(a)2) Established a process for assessing gaps in existing 
cancer control plan activities/strategies.
    G.3.a.(2)(b) Enhance the organizational infrastructure by acquiring 
key staff and associated resources to coordinate and integrate cancer 
prevention and control efforts. This would include efforts to 
prioritize and support the implementation of cancer prevention and 
control activities. Identify and secure resources to support the 
development and dissemination of programs that will contribute to the 
priority areas identified within the comprehensive cancer control plan. 
Support organizational and stakeholder

[[Page 19936]]

participation in national cancer prevention, early detection, and 
control campaigns.
    Performance will be measured by the extent to which the program 
has:
    G.3.a.(2)(b)[1] Put in place the infrastructure for NCCCP including 
staff and other resources.
    G.3.a.(2)(b)[2] Generated support, resources or secured funding for 
implementation of priorities from the comprehensive cancer control 
plan.
    G.3.a.(2)(c) Mobilize support for cancer prevention and control 
activities by assessing, continuing, and building additional support 
(resources, political will, etc.) among the public and private sectors. 
Build new and enhance existing partnerships by identifying, contacting 
and inviting potential key private, professional, voluntary, and 
nonprofit cancer control organizations, policymakers, consumers, 
payers, media, State and Federal agencies, surveillance and data 
agencies, research and academic institutions, and others to become 
members of a new or existing State/Tribe/Territory-wide comprehensive 
cancer control coalition or partnership. Performance will be measured 
by the extent to which the program has used coalitions and partners, 
both within (such as Breast and Cervical Cancer Early Detection 
Programs and the State or Territorial Central Cancer Registry) and 
outside of the organization, in the implementation of the comprehensive 
cancer control plan and sustained these partnerships as ongoing 
entities by such activities as:
    G.3.a.(2)(c)[1] Organizing and using workgroup(s).
    G.3.a.(2)(c)[2] Establishing written responsibilities (e.g., in a 
mission statement or scope of work).
    G.3.a.(2)(c)[3] Establishing written inter-organizational linkages 
(e.g., a Memorandum of Understanding).
    G.3.a.(2)(c)[4] Conducting formal assessment of members' skills and 
needs for education or training.
    G.3.a.(2)(c)[5] Conducting assessments of partnership member 
satisfaction.
    G.3.a.(2)(c)[6] Coordinating and working with partners to implement 
activities.
    G.3.a.(2)(d) Conduct systematic evaluation of the cancer control 
prioritization and implementation process and the program. Evaluate 
progress in meeting goals, process and impact objectives as stated in 
the work plan and implementation plan. Develop objective/quantitative 
measures of effectiveness that will demonstrate accomplishment of 
program goals and objectives and measure intended outcomes. Performance 
will be measured by the extent to which the program has:
    G.3.a.(2)(d)[1] Continuously evaluated and monitored its own 
process and the outcomes of the NCCCP Plan, its objectives and 
activities.
    G.3.a.(2)(d)[2] Developed and monitored measures of effectiveness 
for its proposed activities.
    G.3.a.(3) Recipient Activities for NCCCP (Optional) Additional 
Activities in Colorectal, Ovarian, Prostate and Skin Cancer:
    Applicants who are submitting requests in response to this program 
announcement for NCCCP Implementation Programs have the option to 
submit additional proposal(s) to pursue activities described in their 
Comprehensive Cancer Control Plan addressing colorectal, ovarian, 
prostate and skin cancers. Up to four proposals may be submitted, but 
only one proposal in any cancer area. Activities proposed should be 
evidence-based; developed through coordination and collaboration 
between governmental and non-governmental partners; and reflect 
interventions that have been shown to be effective in similar settings.
    These requests may include the following types of activities 
relating to colorectal, ovarian, prostate and skin cancers:
    G.3.a.(3)(a) Establishment or expansion of campaigns, strategies 
and community-based initiatives to educate priority populations about 
prevention and/or control of these selected cancers.
    G.3.a.(3)(b) Provider education programs about these cancers or 
their associated risk factors.
    G.3.a.(3)(c) Implementation of policy mandates and environmental 
changes important in the prevention and control of these cancers.
    Performance will be measured by the extent to which the program 
completes proposed activities. If all activities are not completed as 
planned, detail should be given on barriers encountered.
G.3.b. CDC Activities
    G.3.b.(1) Assist with the exchange of information and collaboration 
among recipients.
    G.3.b.(2) Provide to recipients relevant, state-of-the-art, 
research findings and public health recommendations related to 
comprehensive cancer control.
    G.3.b.(3) Provide ongoing guidance, consultation, and technical 
assistance in conducting recipient activities.
    G.3.b.(4) Assist with identifying and developing national cancer 
prevention and control campaigns and materials that can be integrated 
into comprehensive cancer control programs.

G.4. Content

    Use the information in Sections G.3. Program Requirements for 
NCCCP, G.4. Content, G.5. Other NCCCP Requirements, and G.6. Evaluation 
Criteria to develop the application content. Your application will be 
evaluated using the criteria listed, so it is important to follow them 
in laying out your program plan.
    Applications should not exceed 30 double-spaced pages including 
budget and justification. Applicants should also submit appendices 
(including curriculum vitae, job descriptions, organizational charts, 
and any other supporting documentation), which should not exceed an 
additional 20 pages (20 page limit excludes State/Tribe/Territory 
cancer plan, if applicable).
G.4.a. NCCCP Application Outline
    Please provide the following information as outlined below.
    G.4.a.(1) Executive Summary:
    The applicant should provide a clear, concise 1-2 page written 
summary to include:
    G.4.a.(1)(a) Need for comprehensive cancer control planning 
activities or implementation activities.
    G.4.a.(1)(b) Identification of the major activities proposed to 
develop or implement a comprehensive cancer prevention and control 
plan.
    G.4.a.(1)(c) Requested amount of Federal funding.
    G.4.a.(1)(d) Applicant's capability to conduct the comprehensive 
cancer control activities.
    G.4.a.(2) Background and Need:
    The applicant should describe:
    G.4.a.(2)(a) The cancer disease burden for the State/Tribe/
Territory, including the most recently available age-adjusted, overall 
cancer incidence and mortality rates by age, gender, and racial and 
ethnic groups. Cite the source for and time period covered by these 
data. Also describe the estimated State/Tribe/Territory cancer 
incidence and mortality rates for 2002.
    G.4.a.(2)(b) Relevant experiences in development and implementation 
of cancer prevention and control programs.
    G.4.a.(2)(c) Relevant experiences in coordination and collaboration 
between and among existing programs.
    G.4.a.(2)(d) Existing initiatives, capacity, and infrastructure 
(e.g., coalitions/partnerships; surveillance activities and systems; 
evaluation activities; information, media and health communications; 
education and outreach strategies) within which comprehensive cancer 
control will occur.

[[Page 19937]]

    G.4.a.(2)(e) Description of the need for comprehensive cancer 
control funding to enhance existing efforts.
    G.4.a.(3) Collaborative Partnerships and Community Involvement:
    The applicant should include:
    G.4.a.(3)(a) A description of the proposed or existing broad-based 
State/Tribe/Territory-wide partnership that will advise and support the 
program in planning and/or implementing comprehensive cancer control 
activities, including a plan for identifying new/additional key 
members, their charge and proposed roles/responsibilities.
    G.4.a.(3)(b) A description of evidence of a broad and diverse level 
of support for and commitment to comprehensive cancer control planning 
or implementation (e.g., legislation supporting cancer prevention and 
control, other sources of funding for comprehensive cancer control, 
dedicated comprehensive cancer control staff); letters of support (in a 
separate tabbed section of the application) that indicate the nature 
and extent of existing or planned collaborative support.
    G.4.a.(3)(c) A plan for collaborating with partners on national 
campaigns or education efforts.
    G.4.a.(4) Management Plan:
    The applicant should:
    G.4.a.(4)(a) Submit a management plan that includes a description 
of proposed management structure that addresses the use of qualified 
and diverse technical, program, administrative staff (including in-kind 
staff), organizational relationships (in the appendices provide a copy 
of the organizational chart indicating the placement of the proposed or 
existing program in a department or agency), internal and external 
communication systems, and a system for sound fiscal management. 
Minimal staffing should include a program coordinator. Applicant should 
clearly indicate who is responsible for ensuring that a comprehensive 
plan is developed and/or implemented.
    G.4.a.(4)(b) Provide a description of the proposed or existing 
linkages within the State/Tribe/Territory health department (e.g., 
across risk factors, categorically funded programs, disciplines) that 
will support integration and coordination within the agency. The 
description of the management structure should include discussion of 
the integration and coordination of risk factors and cancer-related 
programs both within and outside of the funded organization and the 
integration of these programs in the planning or implementation effort. 
It is important that the management plan address how coordination and 
cooperation among existing categorical program efforts will be 
facilitated, while allowing each program to maintain individual 
integrity and identity.
    G.4.a.(4)(c) Provide a description of the proposed core planning or 
implementation team. The core team is traditionally made up of 
individuals both within and outside of the health agency that are 
committed to the development and implementation of the comprehensive 
cancer plan.
    G.4.a.(4)(d) Provide (in the appendices) curriculum vitae and job 
descriptions of key staff to be partially or fully funded through this 
announcement, as well as any staff (who will devote 50 percent or more 
of their time to this program) to be provided through in-kind support.
    G.4.a.(5) Workplan:
    The applicant should provide a detailed work plan that describes 
how comprehensive cancer control activities will be conducted. It 
should include the following:
    G.4.a.(5)(a) Goals and objectives for Year 01.
    G.4.a.(5)(b) Activities planned to achieve objectives.
    G.4.a.(5)(c) Data that will be used to assess program activities.
    G.4.a.(5)(d) Time line for assessing progress.
    G.4.a.(5)(e) The person or persons responsible for activities.
    G.4.a.(5)(f) Overall measures of effectiveness.
    Applicants are required to provide measures of effectiveness that 
will demonstrate the accomplishment of the various identified 
objectives of the cooperative agreement. Measures must be objective/
quantitative and must measure the intended outcome. These measures of 
effectiveness shall be submitted with the workplan, as an element of 
evaluation.
    Grantees may use the attached workplan template to present this 
information (Attachment B--Workplan Template in the appendices). 
Electronic copies of the template will be provided when requested from 
the Program Consultant listed in Section L ``Where to Obtain Additional 
Information''--NCCCP Section.
    G.4.a.(6) Comprehensive Cancer Control Plan: (for Implementation 
Applicants only)
    The applicant should:
    G.4.a.(6)(a) Submit a copy of the existing up-to-date State/Tribe/
Territory-wide comprehensive cancer control plan, or an up-to-date 
draft of a comprehensive cancer control plan. A comprehensive cancer 
control plan should:
    G.4.a.(6)(a)[1] Include an assessment of the cancer burden across 
the State/Tribe/Territory using population-based data.
    G.4.a.(6)(a)[2] Include short-term and long-term goals, measurable 
objectives, proposed strategies to address the cancer burden and 
evaluation plans.
    G.4.a.(6)(a)[3] Be created with diverse partners, inside and 
outside of the State/Tribe/Territory health department, that are 
committed to achieving the goals and objectives of the plan.
    G.4.a.(6)(a)[4] Address cancer prevention, early detection, 
treatment, rehabilitation, palliation and quality of life.
    G.4.a.(6)(b) Describe the process by which the plan was developed. 
If the plan is in draft format, describe the process for ensuring 
readiness for implementation by November 1, 2002. Include a description 
of the participating organizations' involvement in the development of 
the plan. Clearly describe a mechanism to review, evaluate, and update 
the plan to meet changing needs.
    G.4.a.(6)(c) Describe who will be responsible for maintaining the 
comprehensive cancer control plan, assuring that the partnership/
coalition is involved throughout the process, and that comprehensive 
cancer control efforts proceed according to the State/Tribe/Territory's 
plan. Describe how the cancer control plan will be implemented, 
including the process for determining priorities to be addressed in 
implementing the comprehensive cancer control plan, the process for 
assuring that these decisions are data-based or evidence-based and 
grounded in sound science, and the role of the coalition and/or 
collaborators in plan implementation. Describe existing programs funded 
by other sources that will be critical to the successful coordination 
and integration of the proposed comprehensive cancer control effort.
    G.4.a.(7) Itemized Budget and Justification A detailed budget with 
supporting justification must be provided and should be related to 
objectives that are stated in the applicant's workplan.
    Applicants should note the following budget-related issues:
    G.4.a.(7)(a) Indirect Costs:
    If indirect costs are requested, it will be necessary to include a 
copy of your organization's current negotiated Federal Indirect Cost 
Rate Agreement or a Cost Allocation Plan for those grantees under such 
a plan.
    G.4.a.(7)(b) Travel:
    Participation in CDC sponsored training workshops and meetings is

[[Page 19938]]

essential to the effective implementation of the NCPCP. Travel for 
program implementation should be justified and related to 
implementation activities.
    Participation or attendance in non-CDC sponsored professional 
meetings (e.g., ACS, NCI, APHA, other) may be requested but must be 
directly relevant to workplan activities. Participation may include the 
presentation of papers, poster sessions or exhibits on the project. 
Specific requests should be submitted with appropriate justification.
    The annual travel budget should include:
    G.4.a.(7)(b)[1] Travel funds for two staff members to participate 
in two meetings of NCCCP staff in Atlanta, GA for 2-3 days and one 
meeting of NCCCP staff at a regional location for 2-3 days.
    G.4.a.(7)(b)[2] Funds for two staff members to make two, 2-3 day 
trips to Atlanta for CDC-sponsored workshops/meetings, such as the 
National Conference on Chronic Disease Prevention and Control and the 
CDC Cancer Conference.
G.4.b. NCCCP Optional Additional Funding Requests
    Applicants requesting implementation funds through this Program 
Announcement have the option to submit requests to support colorectal, 
ovarian, prostate, and skin cancer activities described in their cancer 
plan. Up to four separate proposals for additional funding (one per 
specific cancer area) may be submitted. Each proposal is limited to 
five pages plus a separate budget and narrative justification.
    Provide separate proposal(s) for activities described in the 
Comprehensive Cancer Control Plan addressing colorectal, ovarian, 
prostate or skin cancers (up to four proposals may be submitted, but 
only one in each of the four selected cancer areas). For each proposal, 
the following information should be submitted:
    G.4.b.(a) Relation to Comprehensive Cancer Control Plan Priority:
    Activities proposed for funding should relate directly to 
components of the Comprehensive Cancer Control Plan to be implemented.
    G.4.b.(b) Evidence-based Activities:
    Proposed activities should be evidence-based; relate to both 
disease burden and demonstrated need and deficiencies; and have been 
shown to be effective in similar settings.
    G.4.b.(c) Organizational Capability:
    The cancer program should document experience, capacity, and 
infrastructure to implement proposed activities.
    G.4.b.(d) Evaluation:
    A proposed plan for evaluating progress toward meeting objectives 
and assessing impact should be included; objectives should be specific, 
measurable, action-oriented, realistic, and time-phased.
    G.4.b.(e) Itemized Budget and Justification See Section G.4.a.(7) 
above for guidance in developing this section of the Application.

G.5. Other Requirements

G.5.a. Progress Report (1 of 2)
    In addition to the general guidance provided in Section J--``Other 
Requirements'', the first of the two required progress reports should 
include a description of:
    G.5.a.(1) Activities accomplished in the current fiscal year, 
presented in relation to what has been proposed and measured by 
measures of effectiveness included in workplan (may submit either in 
narrative or work plan or chart format.)
    G.5.a.(2) Progress in successfully accomplishing recipient 
activities, as measured by performance measures outlined in this 
program announcement.
    G.5.a.(3) An activity that demonstrates the impact of the 
comprehensive cancer control program.
    G.5.a.(4) The technical assistance needs of the cooperative 
agreement recipient.
G.5.b. Moving from a Planning Program to an Implementation Program 
within the five-year Project Period
    For the NCCCP component, the first of the two required progress 
reports may be used as evidence of a NCCCP Planning Program's 
attainment of goals and objectives and the program's readiness to move 
to an Implementation Program award should funds be available. In future 
years, Planning Program grantees wishing to apply for an Implementation 
Program, should submit an application that:
    G.5.b.(1) Demonstrates success in meeting Planning Program 
Performance Measures.
    G.5.b.(2) Fulfills the requirements of the Implementation Program.
    G.5.b.(3) References ``Application Content'' and ``Recipient 
Activities'' section of this program announcement including an itemized 
budget and justification.
    Implementation Program applications will be reviewed by CDC staff 
utilizing a CDC Internal Review process. Applications can be submitted 
in fiscal year 2003, 2004, 2005, or 2006. Applications must be 
submitted (post marked) by February 28 of the fiscal year in which the 
applicant wishes to be considered for Implementation funding.
    Funding decisions may be made on the basis of satisfactory progress 
on the Performance Measures noted for each component as evidenced by 
required reports (semi-annual report), application score, and the 
availability of funds. Performance measures are listed after each 
Recipient Activity.

G.6. Evaluation Criteria

G.6.a. Evaluation Criteria for NCCCP and NCCCP Optional Additional 
Funding
    G.6.a.(1) Planning Programs:
    G.6.a.(1)(a) Background and Need (10 points)
    The extent of need based on disease burden by age, gender and 
racial/ethnic groups, mortality rates, incidence, cancer program 
experience, existing capacity, and infrastructure.
    G.6.a.(1)(b) Collaborative Partnerships and Community Involvement 
(20 points)
    The extent to which the evidence presented demonstrates the breadth 
and appropriateness of the current or proposed broad-based State/Tribe/
Territory-wide coalition/partnership to advise and support 
comprehensive cancer control planning activities.
    G.6.a.(1)(c) Management Plan (30 points)
    The feasibility and clarity of the proposed management plan. The 
extent to which this plan addresses the use of qualified and diverse 
staff, describes proposed or existing linkages within the State/Tribe/
Territory health department to support integration and coordination, 
and describes a proposed core planning team committed to the program.
    G.6.a.(1)(d) Workplan (40 points)
    The extent to which the workplan is feasible, appropriate, 
reasonable and provides a clear description of an evaluation component.
    G.6.a.(1)(e) Budget with Justification (not scored)
    The extent to which the proposed budget is adequately justified, 
reasonable, and consistent with this program announcement and the 
applicant's work plan.
    G.6.a.(2) Implementation Programs:
    G.6.a.(2)(a) Background and Need (10 points)
    The extent of need based on disease burden by age, gender and 
racial/ethnic groups, mortality rates, incidence, cancer program 
experience, existing capacity, and infrastructure.
    G.6.a.(2)(b) Collaborative Partnerships and Community Involvement 
(15 points)
    The extent to which the evidence presented demonstrates the breadth 
and appropriateness of the current or

[[Page 19939]]

proposed broad-based State/Tribe/Territory-wide coalition/partnership 
to advise and support comprehensive cancer control implementation 
activities.
    G.6.a.(2)(c) Management Plan (20 points)
    The feasibility and clarity of the proposed management plan. The 
extent to which this plan addresses the use of qualified and diverse 
staff, describes proposed or existing linkages within the State/Tribe/
Territory health department to support integration and coordination, 
and describes a proposed core implementation team committed to the 
program.
    G.6.a.(2)(d) Workplan (35 points)
    The extent to which the workplan is feasible, appropriate, 
reasonable and provides a clear description of an evaluation component.
    G.6.a.(2)(e) Comprehensive Cancer Control Plan (20 points)
    The quality of the comprehensive cancer control plan in terms of an 
assessment of the cancer burden across the State/Tribe/Territory; 
inclusion of short-term and long-term goals, measurable objectives, and 
proposed strategies to address both the cancer burden and evaluation 
plans; inclusion of diverse partners in development and implementation 
of the cancer plan; and description addressing the full range of cancer 
prevention and control activities (from prevention to quality of life).
    Applications will also be evaluated on the extent to which the 
evidence presented indicates that a broad range of partners and 
stakeholders will be included in reviewing and updating the plan as 
appropriate; mechanisms to review, evaluate and update the plan to meet 
evolving needs, and personnel who will be responsible for maintaining 
the plan, and describes how the cancer control plan will be 
implemented, including a description of existing programs that will be 
critical to the successful coordination and integration of the proposed 
comprehensive cancer control effort.
    G.6.a.(2)(f) Budget with Justification (not scored)
    The extent to which the proposed budget is adequately justified, 
reasonable, and consistent with this program announcement and the 
applicant's implementation plan.
    G.6.a.(3) (Optional) Additional Activities in Colorectal, Ovarian, 
Prostate, and Skin Cancer.
    Optional proposals for additional funding will be reviewed by an 
Objective Review Panel.
    The following are criteria to be used for review of additional 
proposals:
    G.6.a.(3)(a) Consistent with Priority Area Specified in the 
Comprehensive Cancer Control Plan (30 points) The extent to which 
activities proposed in the workplan relate to components of the 
Comprehensive Cancer Control Plan to be implemented.
    G.6.a.(3)(b) Appropriate Activities (30 points)
    The extent to which proposed activities are evidence-based; relate 
to disease burden and demonstrated need; and have been shown to have 
been effective in similar settings.
    G.6.a.(3)(c) Organizational Capability (10 points)
    The extent to which the cancer program has experience, capacity and 
infrastructure to implement proposed activities.
    G.6.a.(3)(d) Evaluation (30 points)
    The extent to which the proposed plan for evaluating progress 
toward meeting objectives and assessing impact appears reasonable and 
feasible; and the degree to which objectives are specific, measurable, 
action-oriented, realistic and time-phased.
    G.6.a.(3)(e) Budget with Justification (not scored)
    The extent to which the proposed budget is adequately justified, 
reasonable, and consistent with this program announcement and the 
applicant's work plan.
    G.6.a.(3)(f) Human Subjects Protection (not scored)
    The extent to which the application adequately addresses the 
requirements of Title 45 CFR Part 46 for the protection of human 
subjects.

H. Specific Guidance for the National Breast and Cervical Cancer 
Early Detection Program (NBCCEDP)

H.1. Eligible Applicants

    Eligible tribal organizations in this category are encouraged to 
collaborate with other tribal organizations in geographic or cultural 
proximity to submit one application. Such collaboration will help to 
maximize the number of women potentially eligible for services under 
this program announcement.

H.2. Availability of Funds

    Approximately $83,000,000 is available to fund 51 existing NBCCEDP 
grantees under Program Announcement Numbers 99052 and 01038. It is 
expected that the average award will be $1,570,000, ranging from 
$117,000 to $6,700,000.
    In addition, approximately $57,000,000 is available in FY 2002 to 
fund 20 to 22 new NBCCEDP recipients. This includes current recipients 
under Program Announcements Numbers 97018 and 96023. It is expected 
that the average award will be $2,680,000, ranging from $200,000 to 
$7,940,000. Requests for these funds will be competitive.
H.2.a. Direct Assistance
    No new direct assistance funds will be awarded in lieu of financial 
assistance to successful NBCCEDP component recipients.
H.2.b. Use of Funds
    H.2.b.(1) 60/40 Requirement: Not less than 60 percent of 
cooperative agreement funds must be spent for screening, tracking, 
follow-up and the provision of appropriate individually provided 
support services. Cooperative agreement funds supporting public 
education and outreach, professional education, quality assurance and 
improvement, surveillance and program evaluation, partnerships, and 
management may not exceed 40 percent of the approved budget [Section 
1503(a)(1) and (4) of the PHS Act, as amended]. Further information 
about the 60/40 distribution is provided in the NBCCEDP Policies and 
Procedure Manual, Section II, beginning on page 10. The NBCCEDP 
Policies and Procedures Manual can be accessed through the Internet at 
http://www.cdc.gov/cancer/nbccedp or by contacting the program 
technical assistant contact listed in Section J, Where to Obtain 
Additional Information.
    H.2.b.(2) Inpatient Hospital Services: Cooperative agreement funds 
must not be spent to provide inpatient hospital or treatment services 
[Section 1504(g) of the PHS Act, as amended]. Refer to the NBCCEDP 
Policies and Procedures Manual, Section IV, ``Reimbursement Policies 
for Screening and Diagnostic Services,'' beginning on page 1, for 
additional information about allowable screening and diagnostic 
services.
    H.2.b.(3) Administrative Expenses: Not more than 10 percent of the 
total funds awarded may be spent annually for administrative expenses. 
These administrative expenses are in lieu of and replace indirect costs 
[Section 1504(f) of the PHS Act, as amended]. Administrative expenses 
comprise a portion of the 40 percent component of the budget.
H.2.c. Recipient Financial Participation
    H.2.c.(1) Matching Requirement Recipient financial participation is 
required for this program in accordance with the authorizing 
legislation. Section 1502(a) and (b)(1), (2), and (3) of the PHS Act, 
as amended, requires

[[Page 19940]]

matching funds from non-Federal sources in an amount not less than one 
dollar for every three dollars of Federal funds awarded under this 
program. However, Title 48 of the U.S. Code 1469a(d) requires DHHS to 
waive matching fund requirements for Guam, U.S. Virgin Islands, 
American Samoa and the Commonwealth of the Northern Mariana Islands up 
to $200,000.
    Matching funds may be cash, in-kind or donated services or 
equipment. Contributions may be made directly or through donations from 
public or private entities. Public Law 93-638 authorizes tribal 
organizations contracting under the authority of Title I to use funds 
received under the Indian Self-Determination Act as matching funds.
    Applicants may also designate as State/Tribe/Territory matching 
funds any non-Federal amounts spent pursuant to Title XIX of the Social 
Security Act for the screening, tracking, follow-up and case management 
of women for breast and cervical cancers.
    Matching funds may not include: (1) Payment for treatment services 
or the donation of treatment services; (2) services assisted or 
subsidized by the Federal government; or (3) the indirect or overhead 
costs of an organization.
    All costs used to satisfy the matching requirements must be 
documented by the applicant and will be subject to audit. Specific 
rules and regulations governing the matching fund requirement are 
included in the PHS Grants Policy Statement, Section 6. Matching funds 
are not subject to the 60/40 requirement described above in H.2.b(1). 
For further information about the matching fund requirement, see the 
NBCCEDP Policies and Procedures Manual, Section II, pages 19-21 and 
page 35.
    H.2.c.(2) Maintenance of Effort: In determining the matching funds 
for the NBCCEDP contribution, applicants should calculate the average 
amount of non-Federal contributions toward breast and cervical cancer 
programs and activities for the two year period preceding the first 
Federal fiscal year of funding for NBCCEDP. This amount is referred to 
as Maintenance of Effort (MOE). Only those non-Federal contributions in 
excess of the MOE amount may be considered as matching funds. 
Supplanting, or replacing, existing program efforts currently paid with 
Federal or non-Federal sources is not allowable.
H.2.d. Funding Preference
    Funding preference may be given to applications from currently 
funded recipients. Preference may also be given to tribal organizations 
that collaborate with other tribal organizations in geographic or 
cultural proximity for the purpose of maximizing the number of women 
potentially eligible for services under this Program Announcement.
H.2.e. Funding Consideration
    Funding Consideration for the NBCCEDP component may be based on:
    H.2.e.(1) Total amount of funding available to support the NBCCEDP. 
See H.2. ``Availability of Funds'' for this information.
    H.2.e.(2) The proportion of funds awarded for NBCCEDP activities 
that were spent during the budget period, if such funds were received 
in the past.
    H.2.e.(3) The appropriate and timely use of unobligated funds from 
previous years, if such funds were received in the past.

H.3. Program Requirements for NBCCEDP

    In conducting activities to achieve the purpose of this program, 
the recipient will be responsible for conducting the activities under 
H.3.a. (Recipient Activities) and CDC will be responsible for the 
activities listed under H.3.b. (CDC Activities).
H.3.a. Recipient Activities
    H.3.a.(1) Provide breast and cervical cancer screening services in 
a timely and appropriate manner to a reasonable number of women 
(negotiated with CDC based upon eligible populations and funds to 
support clinical services) who are under-served, low-income and 
uninsured, with a focus on women from racial and ethnic minority 
populations. Performance will be measured by the extent to which the 
number of eligible women served and their demographic characteristics 
is consistent with projections.
    H.3.a.(2) Refer women with abnormal screening results for 
diagnostic and treatment services in a timely and appropriate manner. 
Performance will be measured by the extent to which data are complete 
when submitted to CDC and the timeliness of diagnostic and treatment 
services meets the 60 day standard.
    H.3.a.(3) Implement a breast and cervical cancer early detection 
program that meets or exceeds expectations in each of the NBCCEDP 
components. Descriptions of the NBCCEDP components, including each 
component's minimum core expectations, can be accessed through the 
Internet at http://www.cdc.gov/cancer/nbccedp or the technical 
assistance contact listed in Section J, ``Where to Obtain Additional 
Information''. A summary of the NBCCEDP Program Components and their 
minimum core elements can be found as Attachment C--NBCCEDP Program 
Component in the appendices. Performance will be measured by the extent 
to which the program meets or exceeds the core elements of each of the 
program components.
    H.3.a.(4) Review progress in meeting objectives and performance 
measures with CDC staff during regular conference calls and/or site 
visits. Evaluate all component activities routinely and use results to 
improve program planning and implementation. Performance will be 
measured by the extent to which there is an evaluation plan for each 
component and evaluation results are used to improve the program.
    H.3.a.(5) Attend CDC-sponsored meetings and training opportunities.
H.3.b. CDC Activities
    H.3.b.(1) Provide ongoing guidance, technical assistance and 
consultation to Grantees to support their planning, implementation and 
evaluation of each NBCCEDP program component. Technical assistance from 
CDC may address:
    H.3.b.(1)(a) Practical application of Public Law 101-354, including 
amendments to the law.
    H.3.b.(1)(b) Design and implementation of program components.
    H.3.b.(1)(c) Interpretation of current scientific literature 
related to the early detection of breast and cervical cancer.
    H.3.b.(1)(d) Interpretation of program outcome, screening and 
surveillance data.
    H.3.b.(1)(e) Overall operational planning and program management.
    H.3.b.(2) Provide relevant public health practice recommendations 
and occasions for exchange of information and collaboration among 
recipients.

H.4. Content

    Use the information in Sections H.3. Program Requirements for 
NBCCEDP, H.4. Content, and H.5 Evaluation Criteria to develop the 
application content. Your application will be evaluated using the 
criteria listed, so it is important to follow them in laying out your 
program plan.
    Applications should not exceed 65 double-spaced pages including 
budget and justification. Appendices (including curriculum vitae, job 
descriptions, organizational charts, and any other supporting 
documentation) are not counted in the 65-page limit.
H.4.a. NBCCEDP Application Outline
    Please provide the following information as outlined below.

[[Page 19941]]

    H.4.a.(1) Capability for Program Implementation (Up to 10 pages)
    Applicants should address their capability to implement proposed 
activities.
    Applicants not currently funded should describe experience with 
other screening programs and their results. Describe relationships with 
key partners who can recruit clients, affect systems, deliver services 
and support the screening program.
    H.4.a.(2) Organizational Support (up to 5 pages)
    The applicant should provide the following information:
    H.4.a.(2)(a) A plan for program management, including an 
organizational chart. Describe those positions which have oversight 
responsibility. Address leadership and administrative plans. Discuss 
strategies for ensuring appropriate communication among key staff on 
the status of program implementation, maintenance, and related issues.
    H.4.a.(2)(b) If the applicant has a cancer registry that has 
achieved NAACCR certification, a plan or description of the current 
process to link data elements (e.g., stage, tumor size, date of 
treatment initiation) related to cancers diagnosed through the program 
with the comparable information in the cancer registry in order to 
verify or correct data. For more information about Cancer Registries 
see http://www.cdc.gov/cancer/npcr, http://www-seer.ims.nci.nih.gov, 
and for NAACCR certification see http://www.NAACCR.org.
    H.4.a.(2)(c) If the applicant currently has or is applying for 
comprehensive cancer control planning or implementation funds, describe 
the ways in which the breast and cervical cancer screening program will 
contribute to and benefit from activities related to comprehensive 
cancer control planning or implementation.
    H.4.a.(3) Identification of Eligible and Priority Populations (Up 
to 2 pages)
    The applicant should describe:
    H.4.a.(3)(a) The number of women who are at or below 250 percent of 
the Federal poverty level and uninsured, by age (18-39; 40-49; 50-64) 
and racial/ethnic distribution (use 2000 Census data, unless it is not 
available). Note that tribes are encouraged to collaborate with other 
tribes in geographic or cultural proximity in order to maximize the 
number of women potentially eligible for services under this program 
announcement.
    H.4.a.(3)(b) The priority populations for screening, including 
supporting data and/or justification for their selection. Describe the 
specific barriers to screening services that impede women in the 
priority populations from participating in breast and cervical cancer 
screening and follow-up services. Broadly, priority populations can be 
described as women who are racial, ethnic and/or cultural minorities, 
such as American Indians, Alaska Natives, African-Americans, Hispanics, 
Asian and Pacific Islanders, lesbians, women with disabilities, and 
women who live in geographically or culturally isolated communities in 
urban and rural areas. The term priority populations, as defined above, 
will be used throughout this document.
    H.4.a.(3)(c) Regardless of the geographic area, priority for breast 
cancer screening should be given to women age 50 to 64 years of age. 
Priority for cervical cancer screening should be given to rarely or 
never screened women, age 18 to 64.
    H.4.a.(4) Workplan (Up to 15 pages)
    For each program component, a detailed workplan and timeline 
including evaluation activities to be accomplished must be submitted 
for the period September 30, 2002 through June 29, 2003. The minimum 
core expectations for each program component should be addressed in the 
workplan. For descriptions of the NBCCEDP components, see Attachment 
C--``NBCCEDP Program Components'' in the appendices. The workplan 
should include the following:
    H.4.a.(4)(a) Measurable goals and objectives.
    H.4.a.(4)(b) Activities planned to achieve objectives.
    H.4.a.(4)(c) Data that will be used to assess program activities.
    H.4.a.(4)(d) Timeline for assessing progress.
    H.4.a.(4)(e) Person or persons responsible for activities.
    H.4.a.(4)(f) Overall measures of success/effectiveness.
    Applicants are encouraged to use the NBCCEDP workplan template 
available through the Internet at http://www.cdc.gov/cancer/nbccedp/training/index.htm.
    Applicants should include an attachment to the workplan with 
realistic screening projections for fiscal year 2002-2003 that are 
based on past screening performance. Applicants who are not currently 
funded by CDC for breast and cervical cancer screening should present 
data about existing programs, if applicable. Screening projections 
should include the number of women to be screened by the program by 
age, race and ethnicity. If women with other characteristics have been 
selected as priority populations, please estimate the number of these 
women to be served. Applicants should include a projection of the 
number of rarely and never screened women to receive a cervical cancer 
screening examination.
    Applicants are encouraged to present screening projections using 
the Screening Projections Matrix, Attachment D--``Screening Projections 
Matrix'' in the appendices.
    The Breast and Cervical Cancer Treatment and Prevention Act of 2000 
(Public Law 106-354) amends Title XIX of the Social Security Act to 
give States the option to provide Medicaid coverage to women who have 
been screened under the NBCCEDP and found to have breast or cervical 
precancerous conditions or cancer. If the applicant has submitted a 
request to the Center for Medicare and Medicaid Services (CMS) under 
this law and received approval, complete Attachment E--``The Breast and 
Cervical Cancer Prevention and Treatment Act Form'' in the appendices. 
Additional information about this law can be obtained from the 
following web site: http://www.cdc.gov/cancer/nbccedp.
    H.4.a.(5) Itemized Budget and Justification (Up to 10 pages)
    A detailed budget with supporting justification must be provided 
and should be related to objectives that are stated in the applicant's 
workplan.
    Applicants should note the following budget-related issues:
    H.4.a.(5)(a) Travel:
    Participation in CDC sponsored training workshops and meetings is 
essential to the effective implementation of the NCPCP. Travel for 
program implementation should be justified and related to 
implementation activities.
    Participation or attendance in non-CDC sponsored professional 
meetings (e.g., ACS, NCI, APHA, other) may be requested but must be 
directly relevant to workplan activities. Participation may include the 
presentation of papers, poster sessions or exhibits on the project. 
Specific requests should be submitted with appropriate justification.
    The annual travel budget should include:
    H.4.a.(5)(a)[1] The Program Director or Coordinator to travel to 
Atlanta, GA to participate in two business meetings of Program 
Directors (2-3 days).
    H.4.a.(5)(a)[2] The Data Manager and one other person to Atlanta, 
GA to participate in the Data Manager's meeting (2-3 days).
    H.4.a.(5)(a)[3] 3-5 persons to attend up to two regional training 
opportunities.
    H.4.a.(5)(a)[4] 3-5 persons to Atlanta, GA, as invited by CDC, to 
report program implementation progress (``reverse site visit'') and for

[[Page 19942]]

consultation/technical assistance or to participate on national work 
groups/committees (two days).
    The following additional guidance relates to the NBCCEDP portion 
only of this program announcement.
    Indicate the 60/40 distribution required by presenting the budget 
in two columns, one containing the 60 percent allowable items and the 
other containing the 40 percent allowable items.
    A sample 60/40 budget breakdown can be found in the NBCCEDP 
Policies and Procedures Manual, Section II, page 38. For further 
information about the 60/40 requirement, please refer to the NBCCEDP 
Policies and Procedures Manual, Section II, page 10.
    The applicant should submit a completed Screening and Diagnostic 
Worksheet (Attachment F--``Screening and Diagnostic Worksheet'' in the 
appendices) which is used to estimate the amount of funding needed to 
reimburse providers for allowable clinical services provided to 
eligible women served in your program. Further information about the 
Screening and Diagnostic Worksheet is provided in the NBCCEDP Policies 
and Procedures Manual, Section IV, pages 21-25. An electronic version 
of the Screening and Diagnostic Worksheet, an EXCEL spreadsheet, may be 
obtained through the program technical assistance contact listed in 
Section L. ``Where to Obtain Additional Information.''
    No new direct assistance funds will be awarded in lieu of financial 
assistance to successful NBCCEDP component applicants.
    H.4.a.(6) Source Data for Matching Requirement (up to 1 page)
    H.4.a.(6)(a) Provide a detailed description of the sources of non-
Federal matching funds by name and the estimated amounts from each for 
the forthcoming fiscal year. Applicants are encouraged to use the 
Sources and Projections of Matching Funds worksheet (See Attachment G--
``Sources and Projections of Matching Funds Worksheet'' in the 
appendices). The applicant should document the procedures for 
determining the value of non-cash matching funds. Describe the 
procedures for documenting the actual match received. Further 
information about the Matching Funds Requirement can be found in the 
NBCCEDP Policies and Procedures Manual, Section II, pages 19-21 and 
page 35.
    H.4.a.(6)(b) Previously funded applicants should provide their 
Maintenance of Effort amount. Applicants not currently funded should 
detail the average amount of non-Federal dollars spent by the applicant 
for breast and cervical cancer programs and activities for the two year 
period preceding the first Federal fiscal year of NBCCEDP funding.
    H.4.a.(7) Letters of Commitment (Up to 10 pages)
    Applicants should include letters of commitment (dated within the 
last three months) from key partners, participants, and community 
leaders that detail their participation in and support of the proposed 
program. If the applicant is a Tribe, also include either of the 
following documentation, as appropriate: 1) A signed and dated tribal 
resolution supporting the application from the Indian Tribe served by 
the project. If the applicant includes more than one Indian Tribe, 
resolutions from all Tribes to be served must be included; or 2) A 
letter of support for the application from the Board of Directors of an 
Urban Indian organization(s) or Indian Health organization(s), signed 
by the Board Chairman.
    H.4.a.(8) Compliance with Program Requirements:
    Requirements and Activities of Public Law 101-354 and related 
Amendments require that funds may not be awarded under this program 
unless the State, Tribe or Territory agrees that:
    H.4.a.(8)(a) Funds will not be spent to make payment for any item 
or service that will be paid or can reasonably be expected to be paid 
by:
    H.4.a.(8)(a)[1] Any State compensation program, insurance policy, 
or Federal or State health benefits program.
    H.4.a.(8)(a)[2] An entity that provides health services on a 
prepaid basis. [Section 1504(d)(1) and (2) of the PHS Act, as amended]
    H.4.a.(8)(b) If charges are to be imposed on clients for the 
provision of services or program activities, such fees/charges for 
allowable screening and diagnostic evaluation will be:
    H.4.a.(8)(b)[1] Assessed according to a schedule of fees made 
available to the public. [Section 1504(b)(1) of the PHS Act, amended]
    H.4.a.(8)(b)[2] Adjusted to reflect the income of the woman 
involved. [Section 1504(b)(2) of the PHS Act, as amended]
    H.4.a.(8)(b)[3] Totally waived for any woman with an income of less 
than 100 percent of the Federal poverty line. [Section 1504(b)(3) of 
the PHS Act, as amended]
    H.4.a.(8)(c) The schedule of fees/charges should not exceed the 
maximum allowable charges established by the Medicare Program 
administered by the Center for Medicare and Medicaid Services, formerly 
Health Care Financing Administration (HCFA). Fee/charge schedules 
should be developed in accordance with guidelines described in the 
interim final rule (42 CFR Parts 405 and 534) which implements Section 
4163 of the Omnibus Budget Reconciliation Act of 1990 (Public Law 101-
508) which provides limited coverage for screening mammography 
services.
    H.4.a.(8)(d) It will assure, in accordance with the applicable law, 
the quality of screening procedures provided.
    H.4.a.(8)(d)[1] All facilities conducting mammography screening 
procedures funded by the Program must be MQSA certified (Mammography 
Quality Standards Act of 1992). [Section 1503(c) of the PHS Act, as 
amended] Additional information about quality assurance is included in 
the NBCCEDP Policies and Procedures Manual, Section II, page 14.
    H.4.a.(8)(d)[2] All facilities conducting cervical screening 
procedures funded by the Program must be CLIA certified (Clinical 
Laboratory Improvement Amendments of 1988). Pathologists participating 
in the program must record their findings using the Bethesda System. 
[Section 1503(c) of the PHS Act, as amended] Additional information 
about quality assurance is included in the NBCCEDP Policies and 
Procedures Manual, Section II, page 14.
    H.4.a.(8)(e) Screening and re-screening procedures are available 
for both breast and cervical cancers and include a clinical breast 
exam, mammography, pelvic exam and Pap test. [Section 1503(a)(2)(A) and 
(B).]
    H.4.a.(8)(f) If a new or improved, and superior, screening 
procedure becomes widely available and is used, this superior procedure 
will be utilized in the program [Section 1503(b) of the PHS Act, as 
amended].
    H.4.a.(8)(g) Women served under the NBCCEDP are those with incomes 
at or below 250 percent of Federal poverty guidelines, who lack 
insurance coverage for these services. The official poverty line is 
established by the Director of the Office of Management and Budget 
(OMB) and revised by the Secretary of the Department of Health and 
Human Services (DHHS) in accordance with Section 673(2) of the Omnibus 
Budget Reconciliation Act of 1991 [Section 1504(a) of the PHS Act, as 
amended]. Policies related to eligibility for screening are detailed in 
the NBCCEDP Policies and Procedures Manual, Section IV.
    H.4.a.(8)(h) Women screened in the Program will receive appropriate 
referrals for diagnostic services and, to the extent practicable, 
appropriate, affordable and timely diagnostic and

[[Page 19943]]

treatment services. [Section 1501(a)(2) of the PHS Act, as amended]
    H.4.a.(8)(i) Breast and cervical cancer screening services are 
established throughout the State, Tribe, or Territory [Section 
1504(c)(1) of the PHS Act, as amended]. Funds may not be awarded under 
this announcement unless the State/Tribe/Territory involved agrees that 
services and activities will be made available throughout the State/
Tribe/Territory, including availability to members of any Indian Tribe 
or tribal organization (as such terms are defined in Section 4 of the 
Indian Self-Determination and Education Assistance Act). CDC may waive 
[Section 1504(c)(2) of the PHS Act, as amended] this requirement if it 
is determined that compliance by the State/Tribe/Territory would result 
in an inefficient allocation of resources with respect to carrying out 
a breast and cervical cancer early detection program [as described in 
Section 1501(a)]. A request from the recipient outlining appropriate 
and detailed justification would be required before the waiver is 
approved.
    H.4.a.(8)(j) The amount paid by a State/Tribe/Territory for a 
screening procedure will not exceed the amount that would be paid under 
part B of Title XVIII of the Social Security Act (Medicare). [Section 
1501(b)(3) of the PHS Act, as amended]
    H.4.a.(8)(k) Funds will be used in a cost-effective manner.
    Applicants should include a statement that indicates that they have 
read and understand that they will be held accountable for items 8a-8k, 
and that they will maintain documentation that would provide proof of 
compliance in the event of a program or fiscal audit.
    In addition, programs must provide the CPT codes and schedule of 
fees for breast and cervical cancer screening and diagnostic services 
to be used by the program. In States/Tribes/Territories where there are 
multiple Medicaid rates and a single reimbursement rate is proposed, 
the applicant must provide justification for approval.

H.5. NBCCEDP Evaluation Criteria

H.5.a. Capability/Commitment (35 points)
    The likelihood that the applicant will be successful in 
implementing the proposed activities as measured by:
    H.5.a.(1) For Currently Funded Applicants:
    H.5.a.(1)(a) Prior performance, as reflected in the discussion of 
progress on meeting objectives in the current workplan and achieving 
the standards of the NBCCEDP program progress indicators.
    H.5.a.(1)(b) The extent to which letters of commitment from key 
partners, participants, and community leaders detail their 
participation in and support of the proposed program.
    H.5.a.(1)(c) If the applicant is a Tribe, the inclusion of a tribal 
resolution(s) or letter of support from the Board of Directors.
    H.5.a.(2) For Applicants Not Currently Funded:
    H.5.a.(2)(a) Prior performance, as reflected in the discussion of 
experience with similar existing programs or audiences.
    H.5.a.(2)(b) Extent to which letters of commitment from key 
partners, participants, and community leaders detail their 
participation in and support of the proposed program.
    H.5.a.(2)(c) If the applicant is a Tribe, the inclusion of a tribal 
resolution(s) or letter of support from the Board of Directors.
H.5.b. Organizational Support (15 points)
    H.5.b.(1) The extent to which the leadership and administrative 
plans presented can reasonably be expected to facilitate the 
achievement of program goals and objectives and the resolution of 
problems.
    H.5.b.(2) If the applicant has or is currently applying for 
comprehensive cancer control planning or implementation funds, the 
extent to which there is evidence that the breast and cervical cancer 
screening program's contributions to and benefits from that activity 
have been discussed.
    H.5.b.(3) If the applicant has a Cancer Registry certified by 
NAACCR, the existence of a data linkage between the NBCCEDP and the 
cancer registry.
H.5.c. Identification of Eligible and Priority Populations (15 points)
    The clarity with which the applicant describes the potentially 
eligible population, the depth of discussion of the selection and 
characteristics of the priority populations and the extent to which 
program activities have been designed to address barriers to care. The 
reasonableness of the projected population to be served based on past 
performance and the proposed recruitment and service delivery system.
H.5.d. Workplan (35 points)
    The degree of comprehensiveness and quality of the workplan as 
measured by the quality of the objectives, the feasibility and 
likelihood of effectiveness of proposed activities to attain the 
objectives, the appropriateness of their related measures of 
effectiveness and the reasonableness of the proposed timeline, for each 
of the NBCCEDP program components.
H.5.e. Budget with Justification (Not Weighted)
    The extent to which the proposed budget is reasonable, justified, 
consistent and in compliance with the program requirements.
H.5.f. Source Data for Matching Requirement (Not Weighted)
    The extent to which the applicant describes the sources and amounts 
of matching funds, the methods for determining the value of non-cash 
match, the methods for documenting the match, the Maintenance of Effort 
amount and, in the case of applicants without current funding, the 
calculation of MOE.
H.5.g. Compliance With Program Requirements (Not Weighted)
    A statement is provided indicating the applicant's understanding 
and acceptance of its accountability for compliance with program 
requirements.

I. Specific Guidance for the National Program of Cancer Registries 
(NPCR)

I.1. Eligible Applicants

    The NPCR component of this program announcement incorporates two 
types of eligibility. The first type is Part I--Enhancement. This type 
of eligibility is defined as a State or territorial health agency or 
its designee that is requesting funds to support and/or enhance an 
existing State cancer registry.
    The second type of NPCR eligibility is Part II--Planning. This type 
of eligibility is defined as a State or Territory with a limited or no 
established State cancer registry that is requesting funds to plan and 
implement a statewide cancer registry.
    Eligible applicants may apply for either Part I (Enhancement) or 
Part II (Planning) but not both.

I.2. Availability of Funds

    Approximately $29,500,000 is available in FY 2002 to fund 49 
existing NPCR grantees under Program Announcement 00027. It is expected 
that the average award will be $649,000, ranging from $48,000 to 
$2,400,000.
    In addition, approximately $500,000 is available in FY 2002 to fund 
two to four new NPCR recipients. It is expected that the average award 
will be $165,000, ranging from $75,000 to $250,000.
    Based on evidence of meeting or exceeding performance standards of 
Planning related activities, and availability of funds, recipients of 
Planning funds do not necessarily need

[[Page 19944]]

to complete the full five year project period before competing for 
Enhancement funds. Unsuccessful applicants for Enhancement funding 
under this scenario would continue with Planning support and would 
continue under their original five year project period.
    Competition is limited in accordance with the authorizing 
legislation, the Cancer Registries Amendment Act (Public Law 102-515; 
Sections 399H-399L of the Public Health Service Act). This legislation 
was re-authorized as part of the Women's Health Research and Prevention 
Amendments of 1998 (Public Law 105-340).
    States applying under Part I may be eligible to be considered for 
funds for advanced activities if they meet NPCR minimum standards or 
criteria for completeness, timeliness, and quality of data. (See 
Appendix I--National Program of Cancer Registries Program Standards 
that lists these standards.)
I.2.a. Direct Assistance
    Applicants may request Federal personnel, as direct assistance, in 
lieu of a portion of financial assistance.
    Requests for new direct-assistance should include:
    I.2.a.(1) Number of assignees requested.
    I.2.a.(2) Description of the position and proposed duties.
    I.2.a.(3) Ability or inability to hire locally with financial 
assistance.
    I.2.a.(4) Justification for request.
    I.2.a.(5) Organizational chart and name of intended supervisor.
    I.2.a.(6) Opportunities for training, education, and work 
experiences for assignees.
    I.2.a.(7) Description of assignee's access to computer equipment 
for communication with CDC (e.g., personal computer at home, personal 
computer at workstation, shared computer at workstation on site, shared 
computer at a central office).
I.2.b. Use of Funds
    No limitations are placed on the use of funds awarded for this 
component in addition to those that are referenced as standard guidance 
in the ``PHS Grants Policy Statement'' (Section 7. Costs Under PHS 
Grant-Supported Projects/Activities).
I.2.c. Recipient Financial Participation
    I.2.c.(1) Matching Requirement (Part I Applicants only)
    Recipients of funds under Part I must agree, with respect to the 
costs of the program, to make available (directly or through donations 
from public or private entities) non-Federal contributions toward such 
costs in an amount that is not less than 25 percent of such costs or 
one dollar for every three dollars of Federal funds provided in the 
grant. [Section 399H(b)(1) of the Public Health Service Act]
    Non-Federal contributions may be in cash or in kind, fairly 
evaluated, including plant, equipment, or services. Amounts provided by 
the Federal government, or services assisted or subsidized to any 
significant extent by the Federal government, may not be included in 
determining the amount of such non-Federal contributions. [Section 
399H(b)(2)(A) of the Public Health Service Act]
    I.2.c.(2) Maintenance of Effort (Part I & Part II Applicants)
    I.2.c.(2)(a) Recipients of funds must agree to make available 
(directly or through donations from public or private entities) non-
Federal contributions equal to the amount expended during the fiscal 
year preceding the first year of the original NPCR grant award for the 
collection of data on cancer.
    I.2.c.(2)(b) In determining the amount of non-Federal contributions 
the recipient may include only those contributions that are in excess 
of the amount of contributions made by the State for collection of data 
on cancer for the fiscal year preceding the first year of the original 
NPCR cooperative agreement award. CDC may decrease the amount of non-
Federal contributions required if the State can show that the amount 
will cause them financial hardship. [Section 399H(b)(2)(B)] Details 
regarding criteria for defining ``financial hardship'' and the process 
for deciding eligibility are included in the application kit.
I.2.d. Funding Preference
    Preference may be given to territorial organizations that 
collaborate with other Territories in geographic or cultural proximity 
for the purpose of maximizing the efficiency of registering cancer 
incidence cases.
I.2.e. Funding Consideration
    Funding consideration for the NPCR Part I--Enhancement component 
may be based on:
    I.2.e.(1) The geographic size of the State.
    I.2.e.(2) The number of expected incident cases during the funding 
period.
    I.2.e.(3) The extent to which data from the cancer registry meet 
the minimum NPCR program standards for completeness, timeliness and 
quality. The NPCR standards by which these data will be evaluated may 
be found in Attachment I--``National Program of Cancer Registries 
Program Standards'' in the appendices.
    I.2.e.(4) The extent to which the cancer registry has been able to 
utilize Federal funding, if funding for the NPCR program has been 
received in the past. Measurement of this criteria will be evaluated 
each year by using the amount of unobligated funds reported on each 
recipients' Financial Status Report for the NPCR component of this 
award. (See Section J.1. ``Technical Reporting Requirements.'') This 
figure will be subtracted from the amount of the initial award to 
obtain the dollar amount spent. The amount spent will be divided by the 
amount of the initial award to obtain the percentage of the award that 
was spent.
    I.2.e.(5) Total amount available to fund NPCR. See Section I.2. 
``Availability of Funds'' for specific amount.

I.3. Program Requirements for NPCR

    In conducting activities to achieve the purpose of this program, 
the recipient will be responsible for conducting the activities under 
I.3.a. (Recipient Activities) and CDC will be responsible for the 
activities listed under I.3.b. (CDC Activities).
I.3.a. Recipient Activities
    I.3.a.(1) Support and enhance (Part I), or plan, implement, and 
support (Part II) the operation of population-based, statewide cancer 
registries in order to collect data concerning: each form of invasive 
cancer with the exception of basal cell and squamous cell carcinoma of 
the skin and each form of in-situ cancer except for carcinoma in-situ 
of the cervix uteri.

    Note: Reportable diagnoses include VIN III, VAIN III, AIN III, 
juvenile astrocytoma, pilocytic astrocytoma, piloid astrocytoma. 
Performance will be measured by the extent to which the program 
complies with CDC's standards for data completeness and quality (See 
Attachment I--``National Program of Cancer Registries Program 
Standards''). Compliance will be determined based on a measurement 
of data submitted through the NPCR-CSS annual call for data.

    Applicants applying for Part I must have a central registry at the 
State level, continuous and recent data collection efforts, existing 
core staff, and written central cancer registry operational policies 
and procedures implemented.
    I.3.a.(2) Collect all required data items. A complete draft listing 
of required and supplementary/recommended data to be collected or 
derived for invasive and in-situ cancers diagnosed after January 1, 
2003, is supplied in the attachment. These requirements will be 
finalized and

[[Page 19945]]

published in Standards for Cancer Registries, Volume II, North American 
Association of Central Cancer Registries (NAACCR), Spring 2002 (NAACCR 
record layout version 10).
    Performance will be measured by the extent to which:
    I.3.a.(2)(a) The information collected or derived on cancer cases 
includes all data elements currently required by the CDC.
    I.3.a.(2)(b) The data codes for all required and recommended data 
elements are consistent with those currently prescribed by CDC.
    The listing of required and supplementary/recommended data items, 
and requirements for code sets, may be revised during the project 
period. Every effort will be made to finalize and disseminate revisions 
for a given diagnosis year no later than April 30th of the previous 
year.
    I.3.a.(3) Develop and/or maintain the capability to import and 
export data in a standard format specified by CDC, in accordance with 
Section 399H(c)(2)(D)(iv) of Public Law 102-515. For cases diagnosed 
during calendar year 2003, NAACCR record layout Version 10 is required. 
(Some data items required for cases diagnosed on or after January 1, 
2003, can only be captured and transmitted using NAACCR record layout 
Version 10.) The required format for data import and export may be 
revised during the project period. Performance will be measured by the 
extent to which the state central registry uses a standardized, CDC-
recommended data exchange record layout for the exchange of data.
    I.3.a.(4) Perform death certificate linkage and follow-back 
annually, in accordance with NAACCR standards, to obtain information on 
date of death, cause of death, and to identify unreported cancer cases. 
Performance will be measured by the extent to which the program has 
complied with NAACCR standards. Compliance will be determined based on 
a measurement of data submitted through the NPCR-CSS annual call for 
data.
    I.3.a.(5) Provide for electronic storage, to the extent possible, 
of all source records including text and codes. Performance will be 
measured by the extent to which the program has documented their 
ability to store required data.
    I.3.a.(6) Participate in an independent audit of compliance with 
NPCR standards as authorized by Section 399H(c)(2)(B)of Public Law 102-
515, conducted by a CDC-approved organization/entity. Audit results 
will be furnished to CDC. Performance will be measured by receipt of 
audit results at CDC prior to the end of the project period.
    I.3.a.(7) Submit cancer data to CDC annually, with the content and 
format specified by CDC as one of the required reports. (See ``Other 
Requirements'' Section.) Performance will be measured by the extent to 
which the program has submitted an analytic data file to CDC with 
individual records containing all requested data elements.
    I.3.a.(8) Establish or enhance, and regularly convene an advisory 
committee to assist in building consensus, cooperation, and planning 
for the statewide cancer registry. Representation should include key 
organizations and individuals such as hospital cancer registrars, 
clinical-laboratory personnel, pathologists, and clinicians. Applicants 
should consider drawing the advisory committee from, or maintaining a 
close relationship with, any existing State cancer control coalition. 
Performance will be measured by the extent to which the program has 
documented meetings of the advisory committee in their progress 
reports.
    I.3.a.(9) Produce an annual report of incidence and mortality rates 
in a timely manner, pursuant to Section 399H (c)(2)(C)of Public Law 
102-515. Performance will be measured by the extent to which the 
program has provided for the publication of an annual report (hardcopy 
or electronic) which includes at minimum, age-adjusted incidence rates 
and age-adjusted mortality rates for the diagnosis year by sex for 
selected cancer sites and, where appropriate, by sex and race and 
ethnicity for selected cancer sites.
    I.3.a.(10) Attend CDC-sponsored meetings and training 
opportunities.
    I.3.a.(11) Participate and collaborate actively in State 
Comprehensive Cancer Control planning efforts. Registry data should be 
the foundation of all evidence based planning efforts that are 
undertaken by NCCCP recipients. Performance will be measured by the 
extent to which the program has documented in their progress reports, 
participation in Comprehensive Cancer Control efforts.
    State Central Cancer Registries should also annually link their 
files with those of the State's NBCCEDP. These linkages can provide an 
additional source of casefinding for the central cancer registry and 
are a valuable data quality improvement tool for both the registry and 
the NBCCEDP.
    I.3.a.(12) Part I Enhancement Advanced Activities:
    States applying under Part I Enhancement may also conduct advanced 
cancer registry activities when the cancer registry demonstrates an 
ongoing capacity to excel in meeting minimum standards. The purpose of 
these activities should be to improve either the data or the operations 
of the cancer registry system. These activities may include but are not 
limited to: aggressive passive case follow-up; active case follow-up; 
needs assessment; geocoding; advanced data security; implementation of 
a cancer inquiry response system; receipt of encrypted case reports via 
the Internet or other source; automated casefinding via linkage with 
pathology reports, disease indices, or other data sources in addition 
to vital records; or linkage with the National Death Index for survival 
analysis; coding of occupation/industry data. Performance will be 
measured by the extent to which the program has documented improvements 
to cancer registry operations and/or data that are directly associated 
with the conduct of the enhanced activity.
I.3.b. CDC Activities
    I.3.b.(1) Convene a meeting for information sharing, problem 
solving, and training at least annually.
    I.3.b.(2) Provide ongoing consultation and technical assistance for 
effective program planning and management, including, but not limited 
to, assistance in the development of model legislation for statewide 
cancer registries; assistance in establishing a computerized reporting 
and data processing system; assistance in establishing a system to 
process source records from multiple institutions to a consolidated 
record; and assistance in monitoring completeness, timeliness, and 
quality of data.
    I.3.b.(3) Provide technical assistance and possible collaboration 
in reporting of cancer rates and other components of an annual report 
on cancer occurrence in the State.
    I.3.b.(4) Conduct site visits to assess program progress and 
mutually resolve problems, as needed.
    I.3.b.(5) Receive, assess, enhance, aggregate and disseminate 
cancer incidence data from grantees for monitoring compliance with the 
terms and conditions of the cooperative agreement and assessment of 
achievement of NPCR program standards and priorities.
    I.3.b.(6) Support quality control audits of State central cancer 
registries.
    I.3.b.(7) Collaborate with State health departments and other 
national partners to establish standards for data completeness, 
timeliness, and quality, and to promote the use of cancer registry data 
to support cancer prevention and control efforts.

[[Page 19946]]

I.4. Content

    Use the information in Sections I.3. Program Requirements for NPCR, 
I.4. Content, I.5 Other NPCR Requirements, and I.6. Evaluation Criteria 
to develop the application content. Your application will be evaluated 
using the criteria listed, so it is important to follow them in laying 
out your program plan.
    Applications should not exceed 50 double-spaced pages including 
budget and justification. Applicants should also submit appendices 
(including curriculum vitae, job descriptions, organizational charts, 
and any other supporting documentation), which should not exceed an 
additional 20 pages.
I.4.a. NPCR Application Outline
    Please provide the following information as outlined below.
    I.4.a.(1) Certifications:
    Non-State public health agency applicants for Part I or Part II 
must provide certification by the State designating the institution as 
the State's official applicant (Sec. 399H(a) and Sec. 399I(a)(2) of the 
Public Health Service Act, respectively).
    I.4.a.(2) Assurances:
    Recipients of funds must provide, as part of their application, 
assurances that they will provide for the authorization under State law 
of the statewide cancer registry, including the promulgation of 
regulations as required by Public Law 102-515; Section 399H(c)(2)(D) of 
the Public Health Service Act and Sections 399H(c)(1) and (2) of the 
Public Health Service Act. Continued funding will be contingent on the 
enactment of authorizing State legislation and promulgation of all 
required State regulations. Applicants for Part I or Part II must 
provide a properly signed Assurance Form in accordance with Section 
399H(c)1 and 2. An Assurance Form is provided in the application 
package.
    I.4.a.(3) Declaration of Federal Assistance Requested:
    Provide a brief summary, one paragraph only, of the type of Federal 
assistance requested: Part I, Enhancement of an existing statewide 
cancer registry, including any requests for funds for advanced 
activities, if applicable; or, Part II, Planning and Implementation of 
a statewide cancer registry.
    I.4.a.(4) Existing Resources and Needs Assessment:
    Applicants for Part I or Part II:
    Describe the current activities of, and any existing limitations 
to, the statewide, population-based, cancer registry including:
    I.4.a.(4)(a) A description of all existing and potential hospital 
and non-hospital sources of cancer cases including in-state and out-of-
state facilities and health care providers that provide cancer 
screening, diagnosis, or treatment to State residents.
    I.4.a.(4)(b) A description of existing electronic cancer reporting 
systems to the State, including hospital, regional, and other tumor 
registries. Such descriptions should include an assessment of data 
entry and data processing procedures and any problems in reporting data 
to the central registry.
    I.4.a.(4)(c) A description of the operations of the central cancer 
registry in the State which includes:
    I.4.a.(4)(c)[1] A listing of data items currently collected.
    I.4.a.(4)(c)[2] An assessment of completeness of cancer reporting 
by year of diagnosis for 1995 and forward, or NPCR reference year and 
forward, as applicable. A description of the method used to estimate 
the expected number of cases and a description of the method for 
determining the completeness of reporting (e.g., the NAACCR method, 
which is used for registry certification and is based on incidence-to-
mortality rate ratios) should be provided.
    I.4.a.(4)(c)[3] An assessment of timeliness of case reporting, 
including a description of the method used to measure timeliness (for 
example, a direct measurement from date of diagnosis or date of first 
contact to date case report received; or, an indirect measurement based 
on the completeness tables provided to CDC each quarter for applicants 
currently funded by NPCR.)
    I.4.a.(4)(c)[4] An assessment of the quality of data for diagnosis 
years 1995 through 2001 and a description of the method for measuring 
specific quality indicators. Indicators may include, but are not 
limited to, the following: The percent of data items coded as either 
unknown or missing for select variables, for example, age at diagnosis, 
sex, race, State and county; the percent of cases which were Death 
Certificate Only; the number of duplicate records per 1000; and the 
percent of cases passing EDITS using, for example, NAACCRs' metafile 
(CINA EDITS).
    I.4.a.(4)(c)[5] A description of on-going quality assurance 
procedures in place for data quality, including but not limited to, 
case-finding and re-abstracting audits, visual editing, and types of 
computerized edits; and a description of any problems with quality 
control.
    I.4.a.(4)(c)[6] A description of existing staff and sources of 
funding support (i.e., State, Federal, or in-kind).
    I.4.a.(4)(c)[7] A description of the flow of data through the 
central cancer registry, including the database design as well as other 
data processing systems. This description should include a brief 
summary of data flow between hospital, regional and other tumor 
registries and the central cancer registry. In addition, this 
description should include steps such as editing, quality control, 
matching, merging, consolidation, feedback to reporting facilities, and 
error resolution, etc.
    I.4.a.(4)(c)[8] Existing uses of cancer registry data.
    I.4.a.(4)(c)[9] A brief description of existing registry policies 
and procedures that are written and currently implemented.
    I.4.a.(4)(c)[10] A description of educational and training 
activities undertaken by central registry staff for both central 
registry and reporting facilities staff. The description should include 
how educational priorities are identified and how they relate to 
information obtained from quality control activities.
    I.4.a.(4)(d) In an appendix, provide the most recent annual report 
of cancer incidence and mortality data. In the absence of a published 
annual report, provide a description of existing cancer data in the 
State, including, but not limited to, age-adjusted incidence/mortality 
rates for cancer for the most recent year available; a discussion of 
limitations, including the lack of availability of cancer rates; 
incompleteness of case ascertainment of all or certain cancer sites; 
and any difficulties identifying race/ethnicity.
    I.4.a.(4)(e) A description of legislation and regulations in place, 
pending legislation, or progress toward introducing legislation that 
legally supports the existence and operation of a State central cancer 
registry. This should include a letter from the applicant's State 
Attorney General or highest ranking State Legal Officer describing to 
what extent the applicant is in compliance with Section 399H(c)(2)(D) 
of the Public Health Service Act which requires the authorization under 
State law of the statewide cancer registry. The letter should also 
document the extent to which the State has promulgated regulations to 
support all eight criteria specified in Section 399H(c)(2)(D) of the 
Public Health Service Act;
    I.4.a.(4)(f) A description of central cancer registry computer 
hardware and software to include:

[[Page 19947]]

    I.4.a.(4)(f)[1] Existing computer equipment for central registry 
operations as well as regional registry operations, if applicable.
    I.4.a.(4)(f)[2] An assessment of the central cancer registry 
software system including strengths and limitations of the system and 
how it is meeting functional requirements of a system as specified in 
the NAACCR Standard Volume III, Standards for Completeness, Quality, 
Analysis, and Management of Data.
    I.4.a.(4)(f)[3] Report-generating capacity of current software 
package(s) needed for management reports, annual reports, special 
studies, and potential cancer cluster investigations.
    I.4.a.(4)(f)[4] Procedures for receiving, matching, and merging 
data from various reporting sites (or facilities), including a 
description of the type of matching system (e.g., deterministic or 
probabilistic).
    I.4.a.(4)(f)[5] Procedures for transmitting data to other central 
cancer registries and a description of the barriers of electronic 
exchange.
    I.4.a.(4)(f)[6] Procedures for matching registry cases with deaths 
in the State mortality database and processing cases for death 
certificate follow-back. Also describe any procedures to match with the 
National Death Index (NDI).
    I.4.a.(4)(f)[7] Procedures for matching registry cases with 
geographic information systems to identify the corresponding census 
tract information.
    I.4.a.(4)(f)[8] Procedures for production of an electronic annual 
report and/or a Web-based query system of a public use data file.
    I.4.a.(5) Management and Staffing Plan: Applicants for Part I or 
Part II:
    Describe how the program will be effectively managed including:
    I.4.a.(5)(a) Management structure, including the lines of authority 
and plans for fiscal control.
    I.4.a.(5)(b) The staff positions responsible for implementation of 
the program.
    I.4.a.(5)(c) Qualifications of the designated or proposed 
management and technical staff.
    I.4.a.(5)(d) A brief description of the training needs/plan for the 
staff. A copy of the organizational chart indicating the placement of 
the proposed program, abbreviated (one page) resumes for designated 
staff, and job descriptions for the proposed staff should be included 
in the application as an appendix.
    I.4.a.(6) Collaborative Relationships: Applicants for Part I and 
Part II:
    Describe, and provide evidence of (or for Part II, describe plans 
for), collaborative relationships between the State and agencies 
relevant to cancer registries or cancer surveillance:
    I.4.a.(6)(a) An advisory committee to assist in building consensus, 
cooperation, and planning for the statewide cancer registry.
    I.4.a.(6)(b) Within the State such as Vital Statistics Office, 
State cancer prevention and control program(s), universities, the 
health care community, hospital associations, and professional and 
voluntary associations.
    I.4.a.(6)(c) With other States or national organizations, such as 
sharing of case data reciprocal agreements and actual sharing of case 
data.
    I.4.a.(6)(d) With Federally-funded programs such as the National 
Breast and Cervical Cancer Early Detection Program; Department of 
Veterans Affairs; Military and Armed Forces facilities; the National 
Cancer Institute's Surveillance, Epidemiology, and End Results Program; 
and Native American Health Boards/Tribal Organizations/Indian Health 
Service in States with Native American populations.
    I.4.a.(6)(e) Identify and describe any proposed new collaborative 
relationships that would enhance registry performance.
    I.4.a.(7) Operational Plan: Applicants for Part I:
    Describe in detail the objectives for the proposed enhancements to 
the existing State cancer registry. These objectives should relate 
directly to the ``Recipient Activities'' listed under ``Program 
Requirements'' and Program Assurances listed under ``Other 
Requirements'' in Section I of this Announcement. The applicant should 
describe the specific outcome and process objectives to directly 
address and resolve the needs identified in the section entitled, 
``Existing Resources and Needs Assessment.'' A projected timetable for 
program implementation and evaluation should be included that displays 
dates for the accomplishment of specific proposed activities.
    I.4.a.(8) Data Utilization:
    Applicants for Part I or Part II:
    Delineate a plan for the use of cancer registry data for cancer 
prevention and control within the State. Examples might include, but 
not be limited to: detailed incidence/mortality estimates; linkage with 
a statewide cancer screening program to improve follow-up of screened 
patients; health-event investigations; needs assessment/program 
planning; program evaluation; and/or descriptive epidemiologic studies.
    I.4.a.(9) Workplan:
    A Year 01 detailed workplan and timeline, including evaluation 
activities to be accomplished must be submitted. The workplan should 
include the following:
    I.4.a.(9)(a) Goals and objectives for Year 01.
    I.4.a.(9)(b) Activities planned to achieve objectives.
    I.4.a.(9)(c) Data that will be used to assess program activities.
    I.4.a.(9)(d) Timeline for assessing progress.
    I.4.a.(9)(e) The person or persons responsible for activities.
    I.4.a.(9)(f) Overall measures of success.
    I.4.a.(9)(g) A plan for program management, including an 
organizational chart. Describe those positions which have oversight 
responsibility. Address leadership and administrative plans. Discuss 
strategies for ensuring appropriate communication among key staff on 
the status of program implementation, maintenance, and related issues; 
and
    I.4.a.(9)(h) Any new or significantly revised items or information 
(objectives, scope of activities, operational methods, evaluation, key 
personnel, workplan, etc.) not included in any previous applications.
    I.4.a.(9)(i) The following components should also be addressed in 
the work plan.
    I.4.a.(9)(i)[1] A plan for achieving all program objectives 
summarized in Attachment I ``NPCR Objectives and Detailed Standards'' 
(e.g. legislation and regulations, uniform data elements, completeness 
of reporting, timeliness of reporting, etc). If appropriate, the plan 
may include improving the completeness or quality of past years' data 
for one or more diagnosis years beginning with the registry's NPCR 
reference year through the 1999 diagnosis year.
    I.4.a.(9)(i)[2] A plan for data use, analysis, and dissemination 
(only from recipients who have achieved NPCR standards for 
completeness, timeliness, and quality).
    I.4.a.(10) Itemized Budget and Justification:
    A detailed budget with supporting justification must be provided 
and should be related to objectives that are stated in the applicant's 
workplan.
    Applicants should note the following budget related issues:
    I.4.a.(10)(a) Indirect Costs:
    If indirect costs are requested, it will be necessary to include a 
copy of your organization's current negotiated Federal Indirect Cost 
Rate Agreement or a Cost Allocation Plan for those grantees under such 
a plan.
    I.4.a.(10)(b) Travel:
    Participation in CDC sponsored training workshops and meetings is

[[Page 19948]]

essential to the effective implementation of the NCPCP. Travel for 
program implementation should be justified and related to 
implementation activities.
    Participation or attendance in non-CDC sponsored professional 
meetings (e.g., ACS, NCI, APHA, other) may be requested but must be 
directly relevant to workplan activities. Participation may include the 
presentation of papers, poster sessions or exhibits on the project. 
Specific requests should be submitted with appropriate justification.
    The annual travel budget should include:
    I.4.a.(10)(b)[1] Travel funds for up to two persons to Atlanta, GA 
to attend the CDC Program Director's Meeting.
    I.4.a.(10)(b)[2] Travel funds to attend national cancer registry 
meetings and applicable workshops.
    I.4.a.(10)(b)[3] Travel funds for up to two persons to Atlanta, GA 
to make one, two-day trip to Atlanta for a reverse site visit.
    The following additional guidance relates to the NPCR portion only 
of this program announcement.
    I.4.a.(10)(c) Financial Participation:
    The level of financial participation by the applicant should also 
be reflected in this section as it relates to:
    I.4.a.(10)(c)[1] Maintenance of Effort: Applicants for Part I or 
Part II:
    Identify and describe the amount of contributions expended during 
the fiscal year preceding the first year of the original NPCR 
cooperative agreement for the collection of data on cancer. The amount 
of contributions will be used to establish a baseline for current and 
future maintenance of effort requirements. [Section 399H(b)]
    I.4.a.(10)(c)[2] Matching Funds: Applications for Part I ONLY:
    Identify and describe:
    I.4.a.(10)(c)[2][a] State sources of allowable matching funds for 
the program and the estimated amounts from each source. The total 
amount of the non-Federal contributions shall be an amount that is not 
less than 25 percent of the total cost of the program including the 
match or one dollar for every three dollars of Federal funds provided 
in the grant. [Section 399H(b)]
    I.4.a.(10)(c)[2][b] Procedures for documenting the value of non-
cash matching funds.
    I.4.a.(11) Appendices:
    The appendices should include new personnel, vacant positions (note 
the duration), health department leadership and organizational changes 
impacting on the program, and legislative impacts on the program.

I.5. Other NPCR Requirements

I.5.a. Technical Reporting Requirments
    In addition to the general reporting requirements that apply to all 
components (Please refer to Section J.1.--``Technical Reporting 
Requirements''.) the following additional Reporting Requirements apply 
to the NPCR component only of this program announcement.
    I.5.a.(1) NPCR Call for Data:
    The first submission will be due in January of each year in the 
form of a Call for Data. Grantees will report a subset of the Required 
and Recommended data items to CDC annually as one of the progress 
reports. Cumulative data will be requested, from the reference year to 
12 months past the close of the diagnosis year. Detailed reporting 
instructions will follow. Annual program evaluation data should also be 
submitted at this time.
    I.5.a.(2) Moving from a Planning Program to an Enhancement Program 
within the five year Project Period.
    For NPCR specifically, the first of the two required progress 
reports may be used as evidence of NPCR's Planning Program's attainment 
of goals and objectives and the program's readiness to move to an 
Enhancement Program award should funds be available. In future years, 
Planning Program grantees wishing to apply for an Enhancement Program, 
should submit an application that:
    I.5.a.(2)(a) Demonstrates success in meeting Planning Program 
objectives to plan, implement, and support the operation of a 
population-based statewide cancer registry.
    I.5.a.(2)(b) References ``Application Content'' and ``Recipient 
Activities'' sections of this program announcement including a line 
item budget and budget justification. See Section I.4.a.(10) ``Itemized 
Budget and Justification'' for general guidance in developing this 
section of the Application. See also Section I.4.a.(10)(c) ``Financial 
Participation'' for additional guidance that is specific to the NPCR 
component.
    Enhancement Program applications will be reviewed by CDC staff 
utilizing an Internal CDC Review process. Applications can be submitted 
in fiscal year 2003, 2004, 2005, or 2006. Applications must be 
submitted (post marked) by February 28 of the fiscal year in which the 
applicant wishes to be considered for Implementation funding.
    Funding decisions may be made on the basis of satisfactory progress 
on the Performance Measures noted for each component as evidenced by 
required reports, application score, and the availability of funds. 
Performance measures are listed after each Recipient Activity.

I.6. NPCR Evaluation Criteria for both Planning and Enhancement 
Programs

I.6.(a) Resources and Needs Assessment (25 points)
    The extent to which the applicant describes current activities and 
existing strengths and limitations of the state-level cancer registry, 
and provides the following:
    (a) A description of all existing and potential sources of cancer 
cases;
    (b) a description of existing computerized cancer reporting systems 
in the State;
    (c) a description of centralized cancer reporting in the State 
including a listing of data items currently collected; an assessment of 
data completeness, timeliness and quality; a description of ongoing 
quality assurance procedures for data quality; a description of 
existing staff, qualifications, and source of funding; a description of 
the flow of data through the central cancer registry; a description of 
existing uses of cancer registry data; a description of existing 
registry policies and procedures that are written and implemented; a 
description of educational and training activities undertaken by 
central registry staff for central registry and reporting facilities 
staff; a copy of the most recent annual report of cancer incidence and 
mortality data or a description of existing cancer data in the State; a 
description of ``enabling'' State legislation and regulations including 
a copy of the State Attorney General's (or highest ranking State Legal 
Officer's) letter of assessment; and a description of existing computer 
hardware and software.
I.6.(b) Collaboration (10 points)
    The extent to which the applicant describes a current or proposed 
advisory committee and describes past, current, and proposed 
collaboration with the relevant organizations and agencies within the 
State; with other States or national organizations; with Federally-
funded health care programs such as the National Breast and Cervical 
Cancer Early Detection Program, Department of Veterans Affairs, 
Military and Armed Forces Facilities, the National Cancer Institute's 
Surveillance, Epidemiology, and End Results Program, and Native 
American Health Boards/Tribal organizations/Indian Health Service in 
States with Native American populations.
I.6.(c) Proposed Objectives (20 points)
    The extent to which objectives are specific, measurable, time-
phased, and

[[Page 19949]]

realistic; provide for outcome and process objectives which meet the 
requirements of Public Law 102-515; and are derived from needs 
identified in the resources and needs assessment.
I.6.(d) Proposed Implementation Plan and Schedule (20 points)
    The extent to which the major steps required for project 
implementation adequately address the needs assessment, are 
realistically described, and the project timetable displays appropriate 
dates for the accomplishment of specific project activities.
I.6.(e) Data Utilization (10 points)
    The extent to which the applicant provides a relevant and realistic 
plan to use cancer registry data within the State for cancer prevention 
and control. The applicant should also address the extent to which they 
have plans for production of an electronic annual report and/or a Web-
based query system of a public use data file.
I.6.(f) Project Management and Staffing Plan (15 points)
    The extent to which proposed staffing, organizational structure, 
staff experience and background, identified training needs or plan, and 
job descriptions and curricula vitae for both proposed and current 
staff indicate ability to carry out the purposes of the program.
I.6.(g) Budget (Not Scored)
    The extent to which the applicant provides a detailed budget and 
justification consistent with the stated objectives and program 
activities.

J. Other Requirements

J.1. Technical Reporting Requirements

    All of the following reporting requirements to be submitted to CDC 
should include an original and two copies of:
J.1.a. Progress Report (1 of 2)
    The first submission will be due February 28 of each year in the 
form of a progress report that succinctly describes progress for the 
period September 30, 2002 thru January 31, 2003 (for the first budget 
period) in meeting stated objectives. In future years, submission of 
this report should cover the period June 30-January 31 (of each year). 
If program objectives were not met, provide an explanation and steps to 
be taken to meet the objectives. This report will also serve as a 
continuation application and should include:
    J.1.a.(1) A workplan with new objectives for the following budget 
period.
    J.1.a.(2) A one year line item budget and justification for the 
same 12 month period.
    J.1.a.(3) A hard copy of the State's most recent annual report on 
cancer incidence.
    J.1.a.(4) Additional component specific information.
    J.1.a.(4)(a) NCCCP:
    See ``Section G.5. Other Requirements'' for specific Guidance on 
the content of this progress report and how Planning Program recipients 
may apply for Implementation Program funds in future years.
    J.1.a.(4)(b) NBCCEDP:
    There is no additional specific information for this component.
    J.1.a.(4)(b) NPCR:
    See ``Section I.5. Other Requirements'' for specific guidance on 
how Planning Program recipients may apply for Enhancement Program funds 
in future years.
J.1.b. Progress Report (2 of 2)
    The second submission will be due July 31 of each year in the form 
of a progress report addressing progress toward achieving objectives 
detailed in the application during the time period from February 1 
through June 30 (5 months).
    All manuscripts published as a result of the work supported in part 
or whole by the cooperative agreement, should be submitted with the 
progress report.
J.1.c. Financial Status Report
    Due no more than 90 days after the end of the budget period with 
unobligated funds tracked separately by component (NCCCP, NBCCEDP, and 
NPCR).
J.1.d. Final Financial and Performance Reports
    Due no more than 90 days after the end of the project period.
    Send all reports to the Grants Management Specialist identified in 
the ``Where to Obtain Additional Information'' section of this 
announcement.

J.2. Additional Requirements for all components

    The following additional requirements are applicable to this 
program. For a complete description of each, see the ``Additional 
Requirements'' attachment in the application kit.

AR-7--Executive Order 12372 Review
AR-9--Paperwork Reduction Act Requirements
AR-10--Smoke-Free Workplace Requirements
AR-11--Healthy People 2010
AR-12--Lobbying Restrictions

    The following additional requirements are applicable to the 
specific components under which they are listed.
J.2.(a) Additional Requirements for NCCCP
    AR-8--Public Health System Reporting Requirements
J.2.(b) Additional Requirements for NBCCEDP:
AR-1--Human Subjects Requirement
AR-2 Requirements for Inclusion of Women and Racial and Ethnic 
Minorities in Research
J.2.(c) Additional Requirements for NPCR
AR-- Human Subjects Requirements
AR--2 Requirements for Inclusion of Women and Racial and Ethnic 
Minorities in Research
AR-21--National Program of Cancer Registries Program Standards
AR-22--Required Status Table

K. Authority and Catalog of Federal Domestic Assistance Number

K.1. NCCCP

    This program is authorized under section 317(k)(2) of the Public 
Health Service Act, [42 U.S.C. section 247b (k)(2)], as amended. The 
Catalog of Federal Domestic Assistance number is 93.283.

K.2. NBCCEDP

    This program is authorized under sections 1501-1510 [42 U.S.C. 
300k, 42 U.S.C. 3001, 42 U.S.C. 300m, 42 U.S.C. 300n, 42 U.S.C. 300 n-
1, 42 U.S.C. 300 n-2, 42 U.S.C. 300 n-3, 42 U.S.C. 300 n-4, 42 U.S.C. 
300 n-4a, 42 U.S.C. 300 n-5] of the Public Health Service Act, as 
amended. The Catalog of Federal Domestic Assistance number is 93.919.

K.3. NPCR

    This program is authorized under sections 399H-399L of the Public 
Health Service Act, [42 U.S.C. sections 280e-280e-4; Public Law 102-
515], as amended. This program was re-authorized as part of the Women's 
Health Research and Prevention Amendments of 1998, Public Law 105-340. 
The Catalog of Federal Domestic Assistance number is 93.283.

L. Where To Obtain Additional Information

    This and other CDC announcements can be found on the CDC home page 
Internet address--http://www.cdc.gov

[[Page 19950]]

Click on ``Funding'' then ``Grants and Cooperative Agreements.''
    If you have questions after reviewing the contents of all the 
documents, business management technical assistance may be obtained 
from: Annie Camacho or Glynnis Taylor, Grants Management Specialist, 
Grants Management Branch, Procurement and Grants Office, Centers for 
Disease Control and Prevention, 2920 Brandywine Road, Room 3000, 
Atlanta, GA 30341-4146.
    Telephone number: Annie Camacho: 770-488-2735, Glynnis Taylor: 770-
488-2752.
    E-mail address: Annie Camacho: [email protected], Glynnis Taylor: 
[email protected].
    For program technical assistance, contact:
    NCCCP: Leslie S. Given, MPA, NCCCP Unit, Program Services Branch, 
Division of Cancer Prevention and Control, National Center for Chronic 
Disease Prevention and Health Promotion, Centers for Disease Control 
and Prevention, 4770 Buford Hwy., NE (MS K-57), Atlanta, GA 30341-3717. 
Telephone number: 770-488-3099. E-mail address: [email protected].
    NBCCEDP: Susan True, M.Ed., Branch Chief, Program Services Branch, 
Division of Cancer Prevention and Control, National Center for Chronic 
Disease Prevention and Health Promotion, Centers for Disease Control 
and Prevention, 4770 Buford Hwy., NE (MS K-57), Atlanta, GA 30341-3717. 
Telephone number: 770-488-4880. E-mail address: [email protected].
    NPCR: Leah Simpson, Program Analyst, Cancer Surveillance Branch, 
Division of Cancer Prevention and Control, National Center for Chronic 
Disease Prevention and Health Promotion, Centers for Disease Control 
and Prevention, 4770 Buford Hwy., NE (MS K-53), Atlanta, GA 30341-3717. 
Telephone number: 770-488-4158. E-mail address: [email protected].

    Dated: April 16, 2002.
Edward J. Schultz,
Acting Director, Procurement and Grants Office, Centers for Disease 
Control and Prevention.
[FR Doc. 02-9724 Filed 4-22-02; 8:45 am]
BILLING CODE 4163-18-P